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Abstract
Carlos Anderson Gutierrez
A MATHEMATICAL MODEL OF A CONTROL SYSTEMS HYPOTHESIS OF NMETHYL-D-ASPARTATE RECEPTOR-MEDIATED ETHANOL DEPENDENCE
AND WITHDRAWAL DYNAMICS
2014/2015
Mary M. Staehle, Ph.D.
Master of Science in Chemical Engineering

The biochemical effects of ethanol on the human brain are manifested through
many neurological pathways. Chronic exposure to the depressant has been shown to
result in physical dependence. Subsequent cessation results in withdrawal symptoms such
as seizures and both short- and long-term changes in neurological activity. One of the
primary conduits implicated in the pathways of ethanol dependence and withdrawal is the
detection of glutamate via N-methyl-D-aspartate (NMDA) receptors (NMDARs). Ethanol
molecules inhibit these receptors, and consequent NMDA-induced glutamatergic changes
can result in dependence on ethanol in order to sustain normal brain function. This study
considers the relocation control of NMDARs in response to chronic alcoholism and
withdrawal as a dynamic control system. Specifically, the system is modeled as a
negative feedback control system with a dual-action relocation controller and an explicit
set point. The model is used to investigate the effects of ethanol consumption frequency,
duration, and magnitude as well as various withdrawal profiles on both the NMDAR
population and withdrawal symptoms. The model results are consistent with published
trends in NMDAR populations in response to ethanol. Simulated results suggest that
withdrawal severity is independent of dependence dynamics, and that regulating the
blood alcohol level throughout the progression of withdrawal can minimize withdrawal
symptoms. Furthermore, the model suggests that the development of dependence is a
function of the frequency of exposure, while the degree of dependence is related to the
combination of duration and magnitude of intoxication. Finally, the model enables the
possibility of capturing individualized patient neuroexcitatory states by adjusting
controller parameters. The mathematical model of NMDAR dynamics provides a
platform for analyzing alcohol dependence, predicting withdrawal severity, and designing
treatments to minimize excitotoxic insult during alcohol withdrawal.
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Chapter 1
Introduction

1.1 Motivation
In the new millennium, alcohol abuse has represented a large healthcare risk that has
steadily grown with time. In the United States alone, hospital discharges for incidents
related to drug abuse grew from 2.5 million in 2004 to 4.6 million in 2009 – an 81%
increase1,2. The frequency of discharges which listed alcohol-related morbidity as the
primary diagnosis has similarly increased from 424,000 discharges in 20043 to 658,000 in
2009 – a 55% increase1,2. In 2012 it was estimated that 17 million American adults
suffered from an alcohol use disorder, 1.4 million of which were treated at specialized
facilities that year4. This leads to significant healthcare costs, which were estimated to
total $223.5 billion in the United States in 20065. The epidemic of alcohol abuse in the
United States has sparked renewed interest in the study of alcohol dependence. Despite
this, much is still unknown about the neurological and biological mechanisms of alcohol
dependence or its epidemiology, disease progression, and optimal treatment.

Chronic alcoholism develops when individuals regularly consume pharmacologically
significant quantities of ethanol over an extended period of time. The constant presence
of ethanol leads to homeostatic adaptations in the brain and neurotransmitter systems to
compensate for neurological effects of ethanol; given enough time, this can lead to a state
where the brain is physically dependent upon ethanol to function6. That is to say that the
brain does not function appropriately without a high concentration of ethanol in the
bloodstream.
1

Once dependence has developed, if the individual ceases to consume alcohol they
may experience symptoms of withdrawal. These symptoms can manifest physically or
emotionally and include anxiety and agitation, sweating, increased blood pressure and
heart rate, altered consciousness, seizures, hallucinations, delirium tremens, cardiac
arrhythmias, or sudden death. Collectively, these symptoms are termed alcohol
withdrawal syndrome and they imply a dysregulation of the body’s internal equilibrium
or homeostasis7, 8. The focus of this work is on the mechanism by which homeostasis is
maintained in response to ethanol and the dynamics of that system through chronic
ethanol ingestion and subsequent withdrawal.

Many studies have implicated neuroexcitatory transmitter systems as part of the
neurological response to ethanol9, 10, the homeostatic development of dependence11-13,
and withdrawal symptoms14-16 and behavior17. In particular, these studies have identified
molecular changes in the excitatory and inhibitory neurotransmission systems which are
modulated by glutamate and gamma-aminobutyric acid (GABA) respectively. It has been
shown that ethanol acts to inhibit the central nervous system by synergistically increasing
GABA activity and decreasing glutamate activity18-20. The dynamic balance of the
excitatory and inhibitory systems and disturbances which affect them are of fundamental
importance to understanding the mechanisms behind the development and withdrawal
from ethanol dependence. This study focuses on the inhibition of glutamate transmission
via glutamate receptors. There are two types of glutamate receptors. Ionotropic or ligandgated receptors are comprised of an extracellular binding site and an ion channel pore
which spans the cell membrane and allows transduction signals. Metabotropic receptors
or G-protein coupled receptors rely on intermediary G-proteins to act on an ion channel
2

rather than operating via direct action21. Of the former type, the ionotropic N-methyl-Daspartate (NMDA) receptor is of particular interest, as it has been most directly related to
withdrawal symptoms such as seizures22 and, consequently, is one of the most widely
studied neuroexcitatory pathways for ethanol. Therefore, while the complete response to
alcohol is likely to involve a multitude of pathways, this work will focus on the role of
NMDA receptors.

1.2 Purpose of Experiment
In this study, the neuroexcitatory system was considered from a dynamic control
systems perspective. The primary goal of this study was to isolate individual system
parameters to gain fundamental insight into the variables that affect the development of
ethanol dependence and withdrawal and the resultant severity of symptoms. To that end,
a model was developed utilizing control system dynamics as a basis. This model was
found to be capable of converging for a broad range of controller parameters and
disturbance profiles and the resultant behaviors were consistent with characteristic
behaviors of the NMDA neuroexcitatory complex in response to ethanol. What follows is
a brief summarization of the process by which this study was conducted.

A two-component controller model with explicit set point was constructed, as
well as a governing system of differential equations describing the dynamic response of
the NMDA population. The control system hypothesis was developed and coded in both
Visual Basic Applications and MATLAB®. A baseline sensitivity study was performed to

3

better understand parameter functions and to select a set of parameters which prominently
displayed characteristic behaviors for further study.

In order to study the effects of system disturbances and sensitivity on ethanol
withdrawal, it is necessary to have some measure of the severity and extent of
withdrawal. Two methods for measuring this are proposed based on analogy to observed
symptoms. The peak value of NMDARs is considered a measure of maximum synaptic
activity and, consequently, the likelihood for the development of seizures. The area under
the NMDAR curve above the original set point is proposed as a measure of adaptive
changes in the neuroexcitatory system.

A variety of ethanol dependence and withdrawal profiles were proposed and
tested to observe the effects that these disturbances had on measures of withdrawal
severity. The frequency and magnitude of consumption were varied to order to study the
development of dependence. Pairs of parameters were studied to determine how results
change based on patient-specific changes in neuroexcitatory dynamics and kinetics. The
final goal is to provide a more methodical method for understanding the conditions which
underlie the development of dependence and subsequent withdrawal in order to provide a
basis for the development of proactive, patient-specific treatment rather than a reactive,
symptomatic regimen.

4

Chapter 2
Literature Review
2.1 NMDA and GABA as a Two-Component Neuroexcitatory Control System

Recent molecular studies of neuroexcitatory activity in mammals have identified
glutamate as the principle neurotransmitter by which excitatory signals are propagated
across a synaptic junction12, 21. A synapse is a junction between neurons that allows
signals to be sent from the presynaptic region (axon) across the synaptic junction to the
postsynaptic density (dendrite) of the next neuron. Studies describe a bimodal
compensatory system that controls neuron activity through mechanisms involving Nmethyl-D-aspartate (NMDA) and gamma-aminobutyric acid (GABA). Glutamate is the
excitatory neurotransmission agent while gamma-aminobutyric acid (GABA) is the
inhibitory neurotransmission agent. The effect that these chemicals have on brain
function is dependent on their activation of NMDA and GABA receptors, both of which
come from families of hetero-oligomeric, ligand-gated ion channels23, 24 and are
cotranslationally assembled from a multitude of subunit types in the endoplasmic
reticulum25. The subunit composition of these receptors has been shown to have
significant effects on resultant physiological and pharmacological properties24, 25.

NMDA and GABA receptors modulate synaptic activity in regions of the brain
such as the hippocampus, nucleus accumbens, cerebral cortex, and striatum12 by fluxing
ions such as Ca2+, Na2+, and Cl- in a voltage- and activity-dependent way19, 23, 24. The
synaptic transmissions are regulated by glutamate availability and lead to substantial
effects on subjects’ behaviors such as impulse control26, memory27, and mood, and can
5

have long-lasting impacts on neuronal development21. Consequently, it has been
proposed that the number, composition, activity, and types of receptors are not constant25.
Rather, activity and composition can change in a cell- and synapse-specific manner in
response to factors such as age23, brain region23, long-term neuronal potentiation25, 28, and
sensory stimuli25, 28.

The dynamic, homeostatic adjustments to the receptor populations trigger
neurochemical cascades which affect the concentrations and activity of calpain, fyn
tyrosine, and Mg2+ among other neurologically active agents, as well as their interactions
with NMDA, GABA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, and
Kainate receptors29. These changes in glutamatergic receptor population and the resultant
cascade effects are the underlying mechanism of synaptic plasticity21, 28 and provide
protective functions that stabilize long-term synaptic efficacy and strength30 as well as
preventing synaptic degeneration and apoptosis31.

It is important to note that the activity of GABA receptors (GABARs) and
NMDA receptors (NMDARs) can be substantially modulated by agonists and
antagonists32, 33. This is because the subunits composing NMDARs and GABARs are
encoded by gene families which confer sensitivity to drugs as well as regional and
functional sensitivity and specificity25,34. Consequently, these receptors are the target of
action for psychotropic drugs such as ketamine, phencyclidine, cocaine, heroin, and
ethanol. NMDA and GABA receptors are implicated in the pharmacological effects of
these drugs32, as well as the development of dependence and negative symptoms of
withdrawal, such as seizures12, 32, 35.

6

There are many theories as to the exact mechanism by which ethanol modulates
the glutamatergic neuroexcitatory system, but it is generally accepted that the result is a
synergistic increase in inihibitory GABA activity and a decrease in excitatory
glutamatergic activity19, 20. This is because alcohol and other psychotropic drugs engage
homeostatic processes which attempt to stabilize the neuronal network by affecting
changes to the number, density, structure, and subunit composition of GABARs and
NMDARs. This study focuses in particular on the response of the NMDAR population to
ethanol and investigates the dynamics of ethanol dependence and withdrawal.

2.2 Neurological Function of NMDA Receptors
Before beginning to construct mechanisms that control neuronal activity in
response to the depressant effects of ethanol, it is of critical importance to understand
synaptic structure and function as well as the role of NMDARs therein. Much of synaptic
function and activity is regulated by the availability of the neurotransmitter glutamate.
This is because glutamate exerts control over both metabotropic glutamate receptors,
which are implicated in signaling cascades that result in the production of secondary
neuronal messengers, as well as ionotropic glutamate receptors, which flux ions such as
sodium, potassium, and calcium when they are activated6, 21. NMDARs are ionotropic
receptors whose activation results in the flux of Ca2+, thereby triggering numerous
intracellular signaling cascades21. Consequently, the intracellular concentrations of
calcium and glutamate are co-dependent, as calcium is effectively released in a
glutamate-dependent manner mediated by NMDARs36. The balance between glutamate
concentration and synaptic activity is critical to normal brain function, as glutamate-gated
7

currents in the hippocampus have cascading symptomatic effects on long-term
potentiation, mood, behavior, and seizure emergence12, 26.

However, not all glutamate affects all glutamate-gated receptors in the same way.
There are two glutamate concentrations which are of interest: synaptic and ambient
concentrations. The synaptic concentration of glutamate is subject to short, high
concentration bursts in response to synaptic signaling21. On the other hand, the ambient
or extracellular glutamate concentration remains relatively constant21. The ambient
concentration of glutamate in brain and neuronal tissue ranges from 5-15 mmol/kg in
human neurons, with the concentration in axon terminals being two to three times higher
due to the synthesis of glutamate occurring locally in the mitochondria21.
Synaptic and ambient glutamate concentrations are mediated by separate populations of
receptors with analogous nomenclature. Synaptic glutamate receptors, which include
NMDARs, are inserted and clustered in the dendritic regions localized in the synapse21.
Approximately half the NMDAR population is synaptic, with the remaining receptors
being located in the extrasynaptic region21.

According to Featherstone, the process of glutamate signaling occurs in several
steps as shown in Figure 121. The first step involves mitochondrial glutamate synthesis
and transport through the cytoplasm of glutamatergic neurons. Second, glutamate is
pumped into a secretory vesicle near the axon that is called a synaptic vesicle. The
synaptic vesicle fuses with the plasma membrane and releases the glutamate into the
synaptic cleft. This creates a burst of increased glutamate concentration that is detected
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and transduced by NMDARs and other glutamate receptors. Excess glutamate is removed
from the synaptic cleft by excitatory amino acid transporters.

9

Figure 1. Glutamate signaling process. Glutamate is synthesized in the mitochondria of
the presynaptic axon terminal and transported to the synaptic vesicle. The vesicle fuses
with the extracellular membrane and releases glutamate into the synaptic cleft. The burst
of high glutamate concentration is detected by ionotropic receptors (iGluR) as well as
metabotropic receptors (mGluR) in the dendritic postsynaptic density. Any excess
glutamate is collected by excitatory amino acid transportors (EAAT) and returned to the
axon. Figure reproduced from Featherstone21.
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To summarize, NMDARs are glutamate-gated excitatory neurotransmitters. When
glutamate is released from the presynaptic region into the synaptic cleft, NMDARs in the
postsynaptic density detect the synaptic glutamate concentrations, and respond by fluxing
Ca2+, allowing the excitatory signal to propagate along the neuronal network. Normal
neuronal function is maintained by achieving an equilibrium between the excitatory
effects of NMDARs and the inhibitory effects of GABA.

2.3 Structure and Function of Ionotropic NMDA Receptors
NMDARs are ligand-gated ion channels with a high permeability to Ca2+ ions19
that are activated by the excitatory amino-acid neurotransmitters glutamate and glycine23,
37, 38

. Particularly, NMDARs are hetero-oligomeric assemblies of NR1, NR2, and NR3

subunit complexes which cotranslationally self-assemble in the endoplasmic reticulum of
the dendritic terminal of the synapse25. Each receptor has at least two active binding sites
for glutamate19. The activity of the receptors is modulated by the allosteric binding of
small compounds to the amino-terminal domain37.

Each subunit type has unique functions and variations. The purpose of the NR1
subunit is to provide the backbone for the receptor complex. It forms the ion channel27
and maintains normal receptor function12. The NR2 subunit builds on the functionality of
the NR1 by mediating the effects of pharmacological agents such as ethanol and
determining the channel kinetics and activity27. In general, the NR2 subunit potentiates
the electrophysical response of the NMDAR. Finally, the role of NR3 subunits is to
regulate the glutamate-gated flux of calcium39.

11

Figure 2. Structure and Binding Sites of NMDARs. NMDARs are heteromeric ion
channels composed of NR1, NR2, and NR3 subunits. The NR1 and NR2 subunits are the
primary active sites, and will always contain an extracellular amino-terminal, intracellular
carboxyl-terminal domain with phosphorylation sites, and binding sites for glutamate and
glycine. NMDARs also contain a number of allosteric binding sites for polyamines, Zn2+,
and protons. These binding sites have a direct effect on the activity of the receptor40.
Figure reproduced from Benarroch40.
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This study focuses on the NR1 and NR2 subunit complexes. NR1 subunits are
required for baseline receptor function, and are consequently a reasonable measure of the
density of receptors. NR2 subunits describe the kinetics and activity and provide a means
of describing changes in receptor functionality as a response to stimuli and disturbances
such as ethanol.

There are four types of NR2 subunits, designated as NR2A, NR2B, NR2C, and
NR2D. Adult neurons are primarily composed of NR1/NR2A and NR1/NR2B
complexes41 with NR2A receptors being primarily synaptic while NR2B receptors are
primarily extrasynaptic38. The reason for this is because these two subunits provide
different properties, specificities, and sensitivities. NR2A subunits provide faster kinetics
as well as greater channel open probability and more prominent desensitization in
response to Ca2+ ions25. NR2B subunits are more sensitive to glutamate10.

NR2 subunits are encoded by a family of genes which determine functional
specificity and sensitivity34, resulting in subunit combinations displaying different
kinetics and divalent action sensitivities32 as well as unique numbers and types of binding
sites and affinities for agonists and antagonists42. As a consequences of these varied
sensitivities, the physical and chemical properties and responses of NMDARs are highly
dependent on receptor composition.
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2.4 Pathways for the Development of NMDA-Mediated Ethanol Dependence
The effects of ethanol on the central nervous system are manifested as selective
and non-competitive inhibition of ligand-gated ion channels, particularly NMDARs18 at
behaviorally relevant levels of ethanol exposure. In general, these levels range from 10100 mM, with 50 mM being accepted as well within the relevant range of intoxication23,
30

. Treatment of NMDARs with agonists such as ethanol results in desensitization of the

receptors, which means a decreased ability for glutamate to generate the typical large,
post-synaptic Ca2+ currents. This behavior can be observed in Figure 343.

Figure 3. Typical synaptic firing behavior. Complexes of NR1, NR2A and NR2B. The
characteristic have fast-onset, burst responses which occur as a result of NMDAR
activation by glutamate. Figure reproduced from Blevins et al41.
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The desensitization of NMDARs by ethanol effectively removes receptors from
the functional pool, thereby affecting activity, trafficking, and localization21.
Consequently, the channel open probability of the NMDARs is reduced in the presence of
ethanol, which inhibits the Ca2+ current generated upon activation22. As a result, the
extrasynaptic concentration of Ca2+ builds up and the neurons adapt to slow-onset, small
changes in Ca2+ rather than the typical behaviors observed above43. This neuronal
tolerance can be developed in as little as minutes23, and long-term exposure can generate
additional negative effects.

There are two theories for explaining the inhibitory effects of ethanol on
NMDARs. The first is that ethanol interacts directly with the receptors, either through an
allosteric or competitive binding site. Studies in the response of NMDARs to antagonists
have shown that the non-competitive blockade of NMDARs produces results which
correspond to chronic ethanol treatment44. This means that ethanol likely binds to
allosteric sites in the ion channel which produces a non-competitive inhibition of
glutamate-mediated responses18. A second theory is that ethanol modulates the activity of
receptors through the addition of PO43- groups (phosphorylation) or by some other
mechanism27. It is likely that the observed inhibitory effects of ethanol cannot be wholly
attributed to one mechanism or the other, but rather that the effects are achieved by a
combination of these and other neurochemical processes.

It has also been observed that varying the duration, frequency, and timedependent profile of ethanol consumption and withdrawal can induce unique patterns of
gene expression9, 42. Because of this dependence, it has been proposed that the adaptive

15

responses occur by multiple, independent post-translational mechanisms45. This is
supported by the fact that chronic ethanol treatment does not significantly alter the shortterm sensitivity of the NMDAR population to acute ethanol exposure46.

This gives rise to the hypothesis that the short- and long-term effects of ethanol
are realized by different pathways. It is currently hypothesized that short-term exposure
to alcohol alters the functionality and sensitivity of existing receptors by altering subunit
and cytoskeleton interactions as well as phosphorylation47. This results in short-term,
subunit specific suppression of receptor function, manifested as an inhibition of
excitatory glutamatergic transmission as observed in Figure 46, 10.

16

Figure 4. Subunit-specific inhibition of NMDAR activity. NR2 splice variants respond to
ethanol in a subunit-specific manner. Here the inhibition is represented as a percent of
normal function (control). This demonstrates the difference in subunit activities and
sensitivity to ethanol. Of particular note is the decreased sensitivity of NR2B in the
presence of ethanol, represented as a percent of the activity of the control sample. Figure
reproduced from Blevins et al41.

Conversely, long-term exposure to ethanol results in increased function and
number of NMDARs in response to chronic inhibition6, 11. This is a result of homeostatic
adaptations in response to decreased receptor activity due to ethanol-mediated
blockage11, the purpose of which is to return stability and normal function to the neuronal
network30. Consequently, it is believed that during chronic ethanol exposure, additional
NMDARs are recruited to the synapse to compensate for the blocked receptor population
and to maintain baseline neuronal activity9, 14, 30, 33. It has also been observed that
blocking excitatory neuronal activity accelerates the trafficking of receptors to the
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synapse25 and that chronic exposure leads to an increase in the clustering of dendritic
binding sites30, 44, particularly in the hippocampus34.

These long-term adaptations in receptor population in response to inhibition are
implicated in the pathways of physical dependence48. The natural adaptation to long-term
inhibition is to upregulate the number and density of binding sites by recruiting additional
receptors33. However, decreased receptor function results in an increase in ambient and
synaptic glutamate concentrations11, 36. As the concentration of ethanol declines,
excitatory activity moves beyond normal function and into a region of hyperexcitability
due to the increased receptor population14. Indeed, patients with chronic ethanol
dependence express higher concentrations of excitatory neurotransmitters33. These
maladaptive changes in receptor population occur as a direct response to chronic
inhibition of NMDARs by antagonists49 and create an environment where normal
function is only possible in the presence of ethanol15, 48, as that reduces the excitatory
load on the neuron to normal levels.

As a consequence of these maladaptive changes, alterations may be observed in a
patient’s control over alcohol intake in order to manage their neuroexcitatory state26. This
type of physical dependence is developed in order to maintain normal brain function in
response to the depressant effects of ethanol6 and the resultant changes in NMDAR
population and density. The relationship between these responses demonstrates that
upregulation of NMDARs is an important substrate for modulating long-term synaptic
efficacy, but is also directly implicated in the development of ethanol tolerance and
dependence12, 19.
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This section describes two mechanisms by which the NMDAR population can be
affected by the presence of ethanol. Short-term exposure results in shifts in NMDAR
activity via phosphorylation and other modulations via allosteric binding sites. These
short-term changes are entirely reversible. Chronic inhibition of NMDARs by ethanol
results in the compensatory recruitment of additional NMDARs from extrasynaptic
regions in order to maintain normal brain function.

2.5 Mechanisms for the Manifestation of the Biochemical Effects of Ethanol on
NMDARs
As outlined in Section 2.4, the dynamics of NMDAR activity can be described by
two primary mechanisms, distinguished by the speed of their responses. Changes in
activity occur quickly, on the order of minutes21, 23, and are believed be the primary
response to acute exposure to ethanol. Chronic exposure, on the other hand, engages
homeostatic upregulation of NMDARs in order to restore normal brain function14, 27, 30.
This two-mechanism system is supported by observations that changes in NMDAR
population activity, composition, and density are time- and dose-dependent9, 30, 42.
Potential pathways by which the activity, composition, and density of the population are
modulated will be discussed in more detail in this section.

There are two primary mechanisms by which the activity of NMDARs can change
in response to various stimuli. First, it must be considered that the composition of the
NMDAR population changes in response to system disturbances. This is supported by
studies that have shown that the polypeptide48 and mRNA levels of NR2B subunits10, 50
are upregulated during chronic ethanol dependence. These behaviors are shown in
19

Figures 5 and 6 respectively. Because NR2B subunits are more sensitive than NR2A10,
this represents a homeostatic response which upregulates activity in response to an
antagonist. By analogy with processes observed during synaptogenesis, it is believed that
the scaffolding protein PSD 95 modulates changes the surface expression of NR2A and
NR2B subunits51.

Figure 5. Expression of NMDAR subunit polypeptides at the synapse changes in
response to chronic ethanol treatment. NR1 and NR2A polypeptides are downregulated,
potentially due to inactivation due to inhibition. NR2B polypeptides are upregulated. This
is likely a homeostatic response to stabilize neuronal activity by increasing the sensitivity
of NMDARs. Figure reproduced from Nagy et al48.
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Figure 6. NMDAR subunit mRNA expression changes in response to chronic ethanol
treatment. mRNA for NR1 and NR2B subunits are upregulated. This represents the
potential for substantial changes in population composition and the insertion of newly
synthesized receptors. Figure reproduced from Follessa et al50.

It is also possible that a multitude of proteins and other neuroexcitatory
transmitters can engage cascades to affect changes in the activity of receptors. There is no
shortage of neurochemical agents that have been implicated in mechanisms which may
attenuate the activity of NMDARs in response to ethanol.

One proposed mechanism is that NMDAR activity is regulated by
phosphorylation of tyrosine phosphatases, as has been shown in the hippocampus52.
Striatal-enriched protein tyrosine phosphatases are brain-specific protein highly
expressed in the striatum, hippocampus, and cortex that form a complex with NR2B
subunits to regulate NMDAR activity27. Research has shown that there is a correlation
between the desphosphorylation via tyrosine phosphatases and the inhibition of receptor
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function27. Fewer tyrosine phosphatases have been shown to reduce NMDAR sensitivity
to ethanol, and inhibitory effects are recovered as the proteins are reintroduced27.
Tyrosine kinase can also be implicated in changes to NMDAR potentiation52.
Insulin receptor activation has been shown to initiate a neurotransmitter cascade that
results in the activation of cystolic tyrosine kinases that may affect NMDAR activity via
phosphorylation52.

It has also been suggested that localization of fyn kinases, particular fyn-rack1
account for NMDAR sensitivity to ethanol in brain regions such as the hippocampus and
dorsal striatum23, 53. NR2B subunits are targeted by fyn-rack1 complexes, and as rack1
dissociates, fyn phosphorylates the NR2B unit and consequently increases receptor
activity. The dissociation is activated by ethanol and occurs via protein kinase A
mediated nuclear translocation54. This hypothesis is further supported by evidence that
fyn kinases and rack1 are only co-localized in brain regions affected by ethanol53, 54.
Anders et al. have proposed that ethanol activates calmodulin, a protein which binds via
the c-terminal domain of the NR1 subunit to enhance calcium-dependent inactivation23.
Ethanol sensitivity has been positively correlated with affinity for calmodulin23.
Littleton et al. have proposed that NMDAR function can be altered by cascades involving
polyamines. NMDARs, particularly those with NR2B subunits have been shown to have
their activity enhanced in the presence of polyamines produced during ethanol exposure
and withdrawal55.
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Finally, nitrous oxides are involved in the long-term maintenance of NMDAR
potentiation by acting as a retrograde messenger45. It is hypothesized that ethanol
stimulates the production of nitrous oxides through neuronal NO synthase isoforms and
that these nitrous oxides regulate several of the membrane-dependent pathways for
realizing NMDAR sensitivity to ethanol47. This is supported by the observation that
administration of NO synthase inhibitors decreases the severity of withdrawal symptoms,
while treatment with nitrous oxide donors results in increased severity45.

However, these short-term mechanisms for controlling synaptic activity do not
account for the adaptive changes in NMDAR population observed in response to chronic
ethanol treatment. In response to consistent inhibition, an increase in the density of active
binding sites for antagonists, such as MK-801, is observed in mammalian hippocampus33,
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. This increase in available binding sites is accompanied by maladaptive upregulation of

mRNA and protein levels of NMDAR subunits44, 49. Interestingly, this upregulation of
NMDAR population does not alter the sensitivity of receptors to acute ethanol
exposure46. This implies that the mechanisms for short- and long-term response are
independent, and that increased activity is not associated exclusively with alterations in
ligand-binding properties or composition11, but rather that receptor population and
density make contributions as well. This means that while bulk increases in population
density of NMDARs at the synapse occur in response to ethanol, other processes for
controlling receptor activity are still engaged30.

Upregulation of NMDARs is achieved by selective, activity-dependent
recruitment of NMDARs to the synapse. These changes in receptor population occur via
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three mechanisms: insertion, lateral movement, or internalization30. This means that
during prolonged periods of inhibition, one would expect to observe the synthesis and
insertion of new receptors at the synapse as well as the relocation of additional receptors
from extrasynaptic region to compensate for reduced sensitivity. The exact mechanism by
which insertion and relocation occur is unknown, but it is hypothesized that the process
involves synapse-associated protein 102 (SAP 102), which trafficks NR2A and NR2B
during synaptogenesis or PDZ domain proteins, which are implicated in intracellular
trafficking and synaptic delivery25, 51. The synthesis hypothesis is consistent with the
observed increase in NR1 and NR2 mRNA in response to ethanol50 (Figure 6), while the
relocation hypothesis is supported by observed increases in NR1 polypeptide expression
unaccompanied by an increase in mRNA expression10, 44.

2.6 Withdrawal Dynamics

Chronic ethanol treatment results in maladaptive regulatory changes in activity,
density, and composition of the synaptic NMDAR population33, 48. As ethanol is purged
from the system, an increase in cerebral activity that enters the regime of hyperactivity is
observed. It is believed that this hyperexcitability is a result of overstimulation of
NMDARs11 in the wake of maladaptive changes at the neuronal level to prolonged
inhibition45. As ethanol is processed and removed from the system, the blockade of
NMDARs is disrupted and neuroexcitatory activity begins to increase. The combination
of increased ambient glutamate and NMDARs as a result of the prolonged blockage
results in a state of hyperexcitability. This state can be observed in Figure 714, 17, 33.
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Figure 7. Prolonged inhibition due to chronic ethanol exposure results in a state of
hyperexcitability upon cessation of treatment. Rats underdoing ethanol withdrawal show
increased synaptic activity in response to direct stimulation of striatal NMDARS via focal
application of NMDA (indicated by the black square) relative to rats that are intoxicated.
Figure reproduced from Rosetti et al36.

Excessive glutamatergic stimulation of NMDARs in the withdrawal state is
believed to enhance the flux of Ca2+, resulting in excessive neuronal activity. This type of
neuronal hyperexcitability is termed excitotoxic and is related to seizures observed in
ethanol withdrawal11, 19, 36, 38. NMDA is the neurotransmitter which has been most
directly related to the development of seizures in response to ethanol withdrawal, despite
the fact that NMDA and GABA are both known initiators of seizures35. This is because
hyperexcitability has been shown be contingent on NMDA independently of other
neurotransmitters14. This is supported by a myriad of studies which show that NMDA and
other NMDAR agonists exacerbate withdrawal symptoms and increase the frequency and
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intensity of seizures33 while NMDAR antagonists such as ethanol and MK-801
ameliorate symptoms15, 32, 33. The electrical activity of neurons corresponding to this
hyperactive excitotoxic state is shown in Figure 8. Additionally, studies have shown that
cells pretreated with ethanol show increased sensitivity to NMDA and other agonists,
requiring ethanol to maintain normal levels of excitation15, 48. This is further supported by
the observation that the primary difference between seizure-prone and seizure-resitant
mice is the density and number of binding sites for NMDA34.
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Figure 8. Neuronal activity varies in response to disturbances to the dependence or
withdrawal state. A1 shows normal response in an ethanol naïve neuron. A2 shows a state
of hyperexcitability after the neuron is exposed to a chronic ethanol treatment and
washed of ethanol to induce withdrawal. B1 shows the response of an ethanol dependent
neuron that has been exposed to (2R)-amino-5-phosphonovaleric acid (APV), an NMDA
antagonist. B2 shows the return of withdrawal seizures once the APV has been washed
from the system. Figure reproduced from Hendricson et al14.
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This ethanol-mediated state of hyperexcitability is implicated in the development
of a number of short- and long-term withdrawal symptoms16. The sharp decline in
NMDAR function during the period shortly following withdrawal is believed to be a
general response to excitotoxic damage, wherein damaged cells undergo apoptosis in
order to prevent the proliferation of damage38. There are two proposed mechanisms that
contribute to this effect. First, the current population is downregulated by the calciumdependent protein calpain-I. In response to the Ca2+ overload in postsynaptic neurons,
calpain-I cleaves the c-terminal regions from NR2A and NR2B subunits38. NMDAR
complexes are stable even when these interactive sequences have been removed from the
NR2 subunits38. The second pathway is to downregulate the synthesis and insertion of
new receptors, rather than the current population. It is believed that Ca2+ overload blocks
the transcription of NR1 subunits, which are necessary for the formation of a functional
ion channel38. It is also proposed that the stable, non-functional receptors impose
geometric limitations on the density of active receptors at the synapse. These pathways
represent long-term mechanisms for downregulation of synaptic activity38. The
downregulation due to inactivation and excitotoxic apoptosis can be observed in Figure 9.
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Figure 9. Chronic ethanol treatment induces NMDAR-mediated neuronal apoptosis. The
left panel shows the effect of chronic ethanol on cell viability. Exposure to ethanol
increases the likelihood of excitotoxic cell death, which decreases viability. The right
panel demonstrates the effect of reintroduction of ethanol into a system in a state of
hyperexcitability. Reintroduction reduces the induction of NMDA-mediated excitotoxic
apoptosis, which implies a dependence on ethanol to maintain normal function. Figure
reproduced from Cebere11.

These changes in neuronal function leading up to, during, and post-withdrawal
persist for approximately 36 hours post-withdrawal, which is consistent with the duration
of withdrawal symptoms22. However, the excitotoxic stimulation of NMDARs in
response to ethanol withdrawal triggers a series of events that result in delayed neuronal
death45 and excitatory downregulation as described previously. The resultant changes in
ambient glutamate and synaptic activity are associated with permanent developmental
and behavioral effects21 and are associated with the gradual development of a seizure
susceptibility56. In fact, NMDAR-mediated neurotoxicity is believed to play a role in the
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development of conditions such as ischemia and epilepsy in which seizures are common
and may be the trigger for degenerative diseases of the brainstem and thalamus, such as
Wernicke-Korsakoff syndrome22,32. It is also observed that increased expression of NR2B
subunits is related to the tendency of patients to relapse13.

This section explores the neuroexcitatory role of NMDARs as a glutamate-gated
ion channel. NMDARs are composed of three types of subunits, each with their own
variations that confer specificity and sensitivity to different pharmacological agents such
as ethanol. The effects of these subunits on ethanol are manifested by two types of
mechanisms. Short-term changes in response to acute ethanol exposure are achieved by
changes in NMDAR activity via allosteric inhibition and phosphorylation cascades.
Long-term changes are achieved by the insertion of new receptors, recruitment of
extrasynaptic receptors to the synaptic region, or internalization of excess receptors.
Extended periods of inhibition result in the compensatory upregulation of the NMDAR
population in order to maintain a normal excitatory state. As ethanol is removed from the
system, this overpopulation causes excessive glutamatergic stimulation which is
associated with the emergence of excitotoxic withdrawal symptoms and subsequent
neuronal damage.
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Chapter 3
Materials and Methods1
3.1 A Control System Description of the Ethanol-NMDAR System
In the hopes of better understanding biological responses to alcohol dependence
and withdrawal at a systemic level, a mathematical model to describe the dynamics of
NMDARs in response to ethanol was developed where the excitatory neurotransmission
process was considered as a negative feedback control system wherein alcohol-induced
blockage of NMDARs functions as a disturbance to normal maintenance of synaptic
activity as described in Figure 10.

Figure 10. Block diagram showing a simplistic description of general system dynamics.
The controller detects unblocked NMDARs as a measure of synaptic activity and takes
appropriate action to restore the system to the desired set point. Alcohol-induced
inhibition of NMDARs functions as a disturbance to the system.
1

Substantial portions of this chapter were adapted from Gutierrez and Staehle57.
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Previous work by Staehle58, 59, investigated descriptions of the NMDAR-ethanol
system utilizing only synthesis and insertion as mechanisms of maintaining synaptic
activity. However, a synthesis-only description is not sufficient to recreate the clinically
relevant results. In order to create the sharp spike in neuronal activity upon cessation as
well as a tendency to return to normal levels of synaptic activity, it is important for the
controller to be able to move NMDARs both to and from the synapse.

This study proposes a composite controller with two active components: an
activity controller that maintains synaptic activity by sending additional receptors to the
synapse, and a density controller that moderates the population of NMDARs at the
synapse by removing active, unblocked receptors from the synapse. Together, these
controllers function to maintain a constant number of active synaptic receptors in the face
of disturbances, such as inhibition of receptors by ethanol, as observed in Figure 11.
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Figure 11. Block diagram of the relocation-only description of the NMDAR-ethanol
system. The net action taken to modify the synaptic activity is the linear combination of
desired actions of the activity and density controllers. Ethanol functions as a disturbance
variable which modulates both the inhibition of NMDARs as well as the strength of the
activity controller, allowing for the balance between the controllers to drift with chronic
intoxication.
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3.2 Developing Governing Equations from Elementary Kinetics
In this study, the NMDAR-ethanol system is considered as a compensatory
negative feedback control mechanism, as described in the control system block diagram
in Figure 11. The overarching control objective here is to maintain normalized brain
function in the presence of ethanol by maintaining a constant level of unblocked
NMDARs (U) at the synapse.

As ethanol is introduced to the system, unblocked receptors (U) become blocked
(B) by alcohol (A) according to a reversible reaction with elementary kinetics, as shown
in Equation 1:

(1)
where k1 = 0.05 hr-1 and k2 = 0.03 hr-1. The number of NMDARs is somehow sensed or
measured by the cell in a process which is assumed to have a perfect gain and negligible
dynamics, akin to most biological sensors. This information is then processed by a twopart composite controller, whose combined action, CT(t), changes the number of
unblocked receptors (U) at the synapse. The overall changes in U and B are therefore
governed by Equations 2 and 3:
𝑑𝑈(𝑡)
𝑑𝑡
𝑑𝐵(𝑡)
𝑑𝑡

= −𝑘1 𝐴(𝑡)𝑈(𝑡) + 𝑘2 𝐵(𝑡) + 𝐶𝑇 (𝑡)

= 𝑘1 𝐴(𝑡)𝑈(𝑡) − 𝑘2 𝐵(𝑡)
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(2)
(3)

3.3 Developing a Bimodal Composite Controller
In order to achieve bi-directional action, the composite controller must be able to
move receptors to and from the synapse. Previous work by Staehle et al. considered a
unidirectional controller with sigmoidal-shaped steady state characteristic activity to
insert newly-synthesized, unblocked NMDARs at the synapse58, 59. That controller was
taken to be of the following form:
𝑎𝑛

𝐶(𝑡) = 𝑦𝑚𝑎𝑥 (𝑈(𝑡)𝑛 +𝑎𝑛 )

(4)

The form of control law selected for this system (Equation 4) is based on similar
mathematical studies of steady state controller action in biological systems60-62, where it
is hypothesized that this sigmoidal formulation captures the physical limitations of
biological processes. In these descriptions, ymax represents the maximum controller
action, while a and n are position and shape parameters that shift steady state controller
activity plots and change the curvature, respectively.

The problem with this formulation is that controller action is only positive. Even
in the case that U(t) is taken as a deviation variable, negative action is possible only if n
is odd. Without a mechanism for reducing the number of receptors at the synapse, this
controller was unable to capture expected behavior during withdrawal. Therefore, for this
study, a dual-mode, bi-directional composite controller for modulation of synaptic
unblocked NMDARs was developed. The first subcontroller, termed the activity
controller, inserts new unblocked NMDARs from an extrasynaptic “pool” based on
current levels of synaptic unblocked NMDARs in an effort to maintain a defined
population of unblocked receptors. The second subcontroller, termed the density
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controller, removes unblocked NMDARs from the synapse in an effort to maintain a
fixed number of NMDARs at the synapse. This controller does not discriminate whether
the synaptic receptor is blocked or unblocked in its assessment of synaptic density, but
only removes active, unblocked NMDARs from the synapse. This behavior was selected
because NMDAR receptor trafficking is activity dependent30 and consequently the
trafficking and localization of receptors blocked by ethanol is inhibited9, 21. It is therefore
assumed that inhibited receptors are inaccessible for the molecular mechanisms
responsible for relocation.

The dual construction yields two subcontrollers of the following forms, where C1
controls relocation to the synapse by the activity controller, C2 controls relocation from
the synapse by the density controller, and CT represents the net control action:
𝑇(𝑡) = 𝑈(𝑡) + 𝐵(𝑡)

(5)

𝑈(𝑡)𝑛1

𝐶1 (𝑡) = 𝑦𝑚𝑎𝑥1 (𝑈(𝑡)𝑛1 +𝑎

𝑛
1 (𝐴) 1

𝑇(𝑡)𝑛2

𝐶2 (𝑡) = −𝑦𝑚𝑎𝑥2 (𝑇(𝑡)𝑛2 +𝑎

𝑛
2 2

)

)

𝐶𝑇 (𝑡) = 𝐶1 (𝑡) + 𝐶2 (𝑡)

(6)
(7)
(8)

The controller activity formulation of Equations 6-8 is complicated by the fact
that the two subcontrollers cause significant deviation in the implicit set point. Changes
to the parameters of either controller shifts the number of receptors at which the
controller actions are balanced, which is the effective set point for the system.
Manipulating parameters to achieve the desired set point is feasible when only one
controller is involved, but with the additional complexity of a second subcontroller, an
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explicit set point is required. The formulation utilizing an explicit set point is provided in
Equations 9-12.
∆𝑈(𝑡) = 𝑈𝐷𝑒𝑠𝑖𝑟𝑒𝑑 − 𝑈(𝑡)

(9)

∆𝑇(𝑡) = 𝑈𝐷𝑒𝑠𝑖𝑟𝑒𝑑 − 𝑇(𝑡) = 𝑈𝐷𝑒𝑠𝑖𝑟𝑒𝑑 − 𝑈(𝑡) − 𝐵(𝑡)
∆𝑈(𝑡)𝑛1

𝐶1 (𝑡) = 𝑦𝑚𝑎𝑥1 (𝑎

𝑛
𝑛
1 (𝐴) 1 +∆𝑈(𝑡) 1

𝐶2 (𝑡) = −𝑦𝑚𝑎𝑥2 (𝑎

∆𝑇(𝑡)𝑛2

𝑛
𝑛
2 2 +∆𝑇(𝑡) 2

)

)

(10)
(11)
(12)

In this formulation, the controller activity is based upon the deviation of the
measured value from the explicit set point. For this study the explicit set point, UDesired , is
defined as 100 receptors. This value is arbitrary and can be scaled according to
biochemical data. It is also assumed that the population of NMDARs in the “pool” is
never limiting and thus the calculated C1 controller activity is always realizable. This is
assumption is valid as long as both controllers are active, and would need to be revisited
for scenarios in which the activity of one controller dominates (e.g. approximations of comorbid disease states). Furthermore, both controllers are constrained in line with
biophysical limitations on their control actions: C1 has no activity if U(t) > UDesired and C2
has no activity if T(t) < UDesired.

Finally, it is necessary to develop a mechanism by which the balance between the
subcontrollers, and consequently the desired set point for NMDAR population, shifts in
response to alcohol intake. Thus, a position parameter of the activity subcontroller, a1,
was defined to be a function of blood alcohol content. In general, with smaller values of
a1, small changes in U create large changes in controller output. As a1 increases, larger
deviations in U are required to obtain the same controller action. To capture the alcohol
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dependency, a1 has been defined as an Arrhenius function deviation from an initial value,
as shown in Equation 13.

𝑎1 (𝐴) = 𝑎𝑥 + 𝑎𝑧 𝑒 −𝑘𝑎𝐴(𝑡)

(13)

The position parameter is defined in this manner so that the controller response is
quick when ethanol content is low but requires larger deviations when alcohol level
increases.

In the development of this control scheme, a number of assumptions about the
glutamatergic neurotransmission system were necessary. First, it is assumed that the
overall glutamate load of these neurons is reasonably constant such that ethanol is the
only stimulus modulating the number of NMDARs required at the synapse. This allows
the disturbances to the system to be described as a single function representing alcohol
intake. Second, it is assumed that synaptic activity is primarily a function of receptor
population and density; the receptor population herein can therefore be considered as a
homogenous population with characteristics of the average composition and activity of
synaptic NMDARs.

3.4 Mathematical Simulation
Two methods were used to simulate this model and determine solutions to the
system of differential equations (Equations 2 and 3). First, a stepwise integration using
Euler’s Method was performed in Visual Basic Applications utilizing a step size of 0.1
hours. This method is necessary to handle cases with any discontinuities.
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In order to validate the results obtained in Visual Basic Applications, this system
was also studied in MATLAB® by differentiating Equations 11 and 12 to obtain a system
of equations as shown below. First, Equation 11 is differentiated yielding the following
result. Recall that a1 is dependent on alcohol, and consequently is a function of time:
𝑑𝐶1
𝑑𝑡

𝑦𝑚𝑎𝑥1
𝑛1 +∆𝑈(𝑡)𝑛1 )2
1

= (𝑎

𝑛1 ∆𝑈(𝑡)𝑛1 −1

𝑑∆𝑈
𝑑𝑡

[(𝑛1 ∆𝑈(𝑡)𝑛1 −1

𝑑∆𝑈
𝑑𝑡

) (𝑎1 (𝑡)𝑛1 + ∆𝑈(𝑡)𝑛1 ) − (𝑛1 𝑎1 (𝑡)𝑛1 −1

𝑑𝑎1
𝑑𝑡

) (∆𝑈(𝑡)𝑛1 )]

+

(14)

A factor of n1 can be pulled out of the differential terms, and the negative can be
distributed.
𝑑𝐶1

𝑦𝑚𝑎𝑥1 𝑛1
𝑛1 +∆𝑈(𝑡)𝑛1 )2
1

= (𝑎

𝑑𝑡

[(𝑎1 (𝑡)𝑛1 ∆𝑈(𝑡)𝑛1 −1

(−𝑎1 (𝑡)𝑛1 −1 ∆𝑈(𝑡)𝑛1

𝑑𝑎1
𝑑𝑡

𝑑∆𝑈
𝑑𝑡

+ ∆𝑈(𝑡)2𝑛1 −1

− ∆𝑈(𝑡)2𝑛1 −1

𝑑∆𝑈
𝑑𝑡

𝑑∆𝑈
𝑑𝑡

)]

)+

(15)

The second term of each of the differential pieces are identical, allowing for the
following simplification:
𝑑𝐶1
𝑑𝑡

= (𝑎

1

𝑦𝑚𝑎𝑥1 𝑛1
𝑛1 +∆𝑈(𝑡)𝑛1 )2

[𝑎1 (𝑡)𝑛1 ∆𝑈(𝑡)𝑛1 −1

𝑑∆𝑈
𝑑𝑡

− 𝑎1 (𝑡)𝑛1 −1 ∆𝑈(𝑡)𝑛1

𝑑𝑎1
𝑑𝑡

]

(16)

Now consider the differential terms as described below to yield the final result, Equation
19.
𝑑∆𝑈
𝑑𝑡
𝑑𝑎1
𝑑𝑡
𝑑𝐶1
𝑑𝑡

−𝑦𝑚𝑎𝑥1 𝑛1
𝑛1 +∆𝑈(𝑡)𝑛1 )2
1

= (𝑎

𝑑𝑈

= − 𝑑𝑡

(17)

= −𝑘𝑎 𝑎𝑧 𝑒 −𝑘𝑎𝐴(𝑡)

(18)

𝑑𝑈

(𝑎1 𝑛1 ∆𝑈(𝑡)𝑛1 −1 𝑑𝑡 + 𝑘𝑎 𝑎𝑧 𝑎1 (𝑡)𝑛1 −1 ∆𝑈(𝑡)𝑛1 𝑒 −𝑘𝑎𝐴(𝑡)

A similar treatment is applied to Equation 12, wherein it is first differentiated:
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𝑑𝐴(𝑡)
𝑑𝑡

) (19)

𝑑𝐶2
𝑑𝑡

−𝑦

= (∆𝑇(𝑡)𝑛𝑚𝑎𝑥2
[(𝑛2 ∆𝑇(𝑡)𝑛2 −1
2 +𝑎 𝑛2 )2
2

(𝑛2 ∆𝑇(𝑡)𝑛2 −1

𝑑∆𝑇
𝑑𝑡

𝑑∆𝑇
𝑑𝑡

) (𝑎2 𝑛2 + ∆𝑇(𝑡)𝑛2 ) −

) (∆𝑇(𝑡)𝑛2 )]

(20)

A factor of n2 can be pulled out and the products distributed to show that the last two
terms are equal and opposite, consequently dropping out:
𝑑𝐶2
𝑑𝑡

−𝑦

𝑛2

= (∆𝑇(𝑡)𝑚𝑎𝑥2
𝑛2 +𝑎

2

𝑑∆𝑇

𝑛2 )2

𝑑𝐶2
𝑑𝑡

𝑑𝑡

[𝑎2 𝑛2 ∆𝑇(𝑡)𝑛2 −1 + ∆𝑇(𝑡)2𝑛2 −1 − ∆𝑇(𝑡)2𝑛2 −1 ]

−𝑦

𝑛2

= (∆𝑇(𝑡)𝑚𝑎𝑥2
𝑛2 +𝑎

𝑛 2
2 2)

(𝑎2 𝑛2 ∆𝑇(𝑡)𝑛2 −1

𝑑∆𝑇
𝑑𝑡

)

(21)
(22)

Now consider the derivative of the total number of receptors at the synapse, and pull out
the resultant negative to obtain the final result, Equation 25.
𝑑∆𝑇
𝑑𝑡
𝑑𝐶2
𝑑𝑡
𝑑𝐶2
𝑑𝑡

−𝑦

𝑛2

= (∆𝑇(𝑡)𝑚𝑎𝑥2
𝑛2 +𝑎

𝑛 2
2 2)

𝑦

𝑑𝑈

𝑑𝐵

= − 𝑑𝑡 − 𝑑𝑡

(23)
𝑑𝑈

[𝑎2 𝑛2 ∆𝑇(𝑡)𝑛2 −1 (− 𝑑𝑡 −

𝑛

𝑑𝑈

2
𝑛2
= (∆𝑇(𝑡)𝑚𝑎𝑥2
∆𝑇(𝑡)𝑛2 −1 ( 𝑑𝑡 +
𝑛2 +𝑎 𝑛2 )2 [𝑎2
2

𝑑𝐵

𝑑𝐵
𝑑𝑡

𝑑𝑡

)]

)]

(24)
(25)

The system of differential equations described by Equations 2, 3, 19, and 25 were solved
using an ordinary differential equation solver (ode15s) in MATLAB®.
For the purposes of validation, it is important to note that both the absolute
controller action and its derivative are consistent with the form used in previous work as
ymax2 and az approach zero. When controller action is described in terms of a deviation
variable, it takes the following form:
𝑎𝑛

𝐶(𝑡) = 𝑦𝑚𝑎𝑥 (1 − 𝑈(𝑡)𝑛 +𝑎𝑛 )
𝑈(𝑡)𝑛 +𝑎𝑛

(26)
𝑈(𝑡)𝑛

𝑎𝑛

𝐶(𝑡) = 𝑦𝑚𝑎𝑥 (𝑈(𝑡)𝑛 +𝑎𝑛 − 𝑈(𝑡)𝑛 +𝑎𝑛 ) = 𝑦𝑚𝑎𝑥 (𝑈(𝑡)𝑛 +𝑎𝑛 )
In the limit that ymax2 goes to zero, the composite controller action takes the following form:
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(27)

lim

𝑦𝑚𝑎𝑥2 →0

∆𝑈(𝑡)𝑛1

𝐶𝑇 (𝑡) = 𝑦𝑚𝑎𝑥1 (𝑎

) − 𝑦𝑚𝑎𝑥2 (𝑎

∆𝑇(𝑡)𝑛2

𝑛
𝑛
2 2 +∆𝑇(𝑡) 2

𝑛
𝑛
1 (𝐴) 1 +∆𝑈(𝑡) 1

∆𝑈(𝑡)𝑛1

𝐶𝑇 (𝑡) = 𝑦𝑚𝑎𝑥1 (𝑎

𝑛
𝑛
1 (𝐴) 1 +∆𝑈(𝑡) 1

)

(28)

)

(29)

A similar proof can be performed for the derivative of the respective control actions.
Using the quotient rule:
𝑑𝐶(𝑡)
𝑑𝑡

=

𝑦𝑚𝑎𝑥
𝑑𝑈
(𝑛𝑈(𝑡)𝑛−1 (𝑈 𝑛
(𝑈(𝑡)𝑛 +𝑎 𝑛 )2
𝑑𝑡
𝑑𝐶(𝑡)
𝑑𝑡

𝑦𝑚𝑎𝑥 𝑛𝑎𝑈(𝑡)𝑛−1

=

+ 𝑎𝑛 − 𝑈 𝑛 ))

(30)

𝑑𝑈
𝑑𝑡

(31)

(𝑎 𝑛 +𝑈(𝑡)𝑛 )2

Similarly, when the composite controller action is considered and the limit as ymax2 and az
approach zero is taken:
lim

𝑑𝐶𝑇

𝑦𝑚𝑎𝑥2 →0 𝑑𝑡

𝑘𝑎 𝑎𝑧 𝑎1 (𝑡)𝑛1 −1 ∆𝑈(𝑡)𝑛1 𝑒 −𝑘𝑎𝐴(𝑡)
𝑑𝐶𝑇
𝑑𝑡

(𝑡) =

−𝑦𝑚𝑎𝑥1 𝑛1
(𝑎1 𝑛1 +∆𝑈(𝑡)𝑛1 )2

𝑑𝐴(𝑡)
𝑑𝑡

𝑦

(𝑡) =

−𝑦𝑚𝑎𝑥1 𝑛1
(𝑎1 𝑛1 +∆𝑈(𝑡)𝑛1 )2

𝑛

𝑑𝑈

(𝑎1 𝑛1 ∆𝑈(𝑡)𝑛1 −1 𝑑𝑡 +
𝑑𝑈

2
𝑛2
) + (∆𝑇(𝑡)𝑚𝑎𝑥2
∆𝑇(𝑡)𝑛2 −1 ( 𝑑𝑡 +
𝑛2 +𝑎 𝑛2 )2 [𝑎2
2

𝑑𝑈

(𝑎1 𝑛1 ∆𝑈(𝑡)𝑛1 −1 𝑑𝑡 + 𝑘𝑎 𝑎𝑧 𝑎1 (𝑡)𝑛1 −1∆𝑈(𝑡)𝑛1 𝑒 −𝑘𝑎𝐴(𝑡)
lim

𝑑𝐶𝑇

𝑎𝑧 →0 𝑑𝑡

(𝑡) =

𝑦𝑚𝑎𝑥1 𝑛1 𝑎1 𝑛1 ∆𝑈(𝑡)𝑛1 −1

𝑑𝐵
𝑑𝑡

)] (32)

𝑑𝐴(𝑡)
𝑑𝑡

𝑑∆𝑈
𝑑𝑡

(𝑎1 𝑛1 +∆𝑈(𝑡)𝑛1 )2

)(33)

(34)

This shows that these two controller formulations are identical, allowing for the
simplification of additional layers of complexity which are considered in this study.

3.5 Alcohol and Withdrawal Profiles
One of the goals of this study was to determine the effect of varying ethanol
dependence and withdrawal profiles on the development of withdrawal symptoms. To
that end, a variety of disturbance profiles were proposed and tested utilizing the model as
derived previously.
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The base case was previously developed by Staehle, wherein alcohol was
represented by a chronically increasing sinusoid with fixed periodicity and abrupt
withdrawal at a specified time tw, as described in Equation 26:
0
sin(𝑝𝑡) < 0
0
𝐴(𝑡) = {
𝑓𝑜𝑟
𝑡 > 𝑡𝑤
𝑍𝑠𝑖𝑛(𝑝𝑡)exp(𝑔𝑡)
𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒

(26)

The periodicity parameter, p, describes the frequency of alcohol consumption, g
describes the growth of ethanol consumption over time, tw is the time at which the desired
withdrawal profile is imposed, and Z provides a scaling factor for normalizing the
dimensionless alcohol level. As in previous work58, 59, the parameters used for the base
case were p = 0.75 hr-1, g = 5x10-4 hr-1, tw = 500 hr, and Z = 1. This case can be seen in
Panel A of Figures 12 and 13.

Additional ethanol disturbance functions were developed to investigate the system
response to varying dependence and withdrawal paradigms. Figure 12 and 13 show each
of the unique dependence and withdrawal profiles respectively.
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Figure 12. Four distinct ethanol dependence profiles are considered as disturbance
functions. The four dependence profiles are: (A) sinusoidal; (B) linear; (C) step-up; (D)
random consumption with exponential decay. All include abrupt withdrawal at
tw = 500 hours.
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Figure 13. Four distinct withdrawal profiles are considered. The four withdrawal profiles
are: (A) abrupt; (B) step-down; (C) linear; (D) exponential decay. All include increasing,
sinusoidal consumption leading up to withdrawal at tw = 500 hours.

3.6 Measures of Withdrawal
One of the primary purposes of this study was to determine the effects of varying
patterns of consumption on the development of dependence and subsequent withdrawal.
To that end, it is necessary to develop mathematical analogues to the development of
both acute withdrawal symptoms as well as the more long-term consequences in order to
enable the quantitative comparison of predicted severity.

Two measures have been proposed to measure the extent and severity of
withdrawal: maximum synaptic NMDAR population and area under the NMDAR curve.
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The first is the peak value of NMDARs at the synapse. One of the assumptions built into
the relocation-only model is that activity is directly related to the density of receptors at
the synapse. Consequently, the point of maximum hyperexcitability is hypothesized to a
reasonable measure of the peak excitotoxic activity and resultant probability or severity
of withdrawal-induced seizures.

The second measure of withdrawal is the area between the NMDAR curve and the
explicit set point. The purpose of this measure is to determine the long-term deviation
from normal brain function in the wake of ethanol withdrawal due to lasting changes to
NMDAR population function, composition, and density. The area under the curve was
calculated as an approximate integral between the explicit set point and the actual
unblocked receptor curve following the initiation of withdrawal. This calculation was
conducted using a midpoint approximation for all points after the initiation of withdrawal
where the number of unblocked NMDARs was above the set point. The time step for this
approximation was 0.1 hours.
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Chapter 4
Results and Discussion2
4.1 A Control Systems Model of Dynamic NMDAR Populations
In the hopes of better understanding biological responses to alcohol dependence
and withdrawal at a systemic level, a mathematical model was developed to describe the
dynamics of NMDARs in response to ethanol where the excitatory neurotransmission
process was considered as a negative feedback control system. As described in Chapter 3,
a composite controller was considered with two active components: an activity controller
that maintains synaptic activity by sending additional receptors to the synapse, and a
density controller that moderates the population of NMDARs at the synapse by removing
active, unblocked receptors from the synapse. Together, these controllers function to
maintain a constant number of active synaptic receptors in the face of disturbances, such
as inhibition of receptors by ethanol.

When simulated with the alcohol profile given in Equation 26 (Figure 12A), the
model described in the Methods section with Parameter Set A (Table 1) produced results
(Figure 14) that are qualitatively consistent with experimental data in four distinct ways:
(1) the synaptic NMDAR population increases with alcohol (Figure 14C)9, 10, 12, 14, 30, 32, 33,
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; (2) alcohol consumption paradigms affect the severity of outcomes9, 42; (3) an

excitotoxic withdrawal response is observed6, 11, 14, 22; and (4) NMDAR populations return
to normal levels over time33.

2

Substantial portions of this chapter were adapted from Gutierrez and Staehle57.
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Here, the explicit set point was fixed at an arbitrary value of 100 NMDARs at the
synapse, as indicated by the dashed line in Figure 14C. As alcohol molecules block the
active, unblocked receptors, the composite controller attempts to maintain the set point
value by receptor translocation to (activity controller, dark red) and from (density
controller, navy blue) the extrasynaptic pool of receptors (Figure 14B).
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Figure 14. Simulated model response to alcohol consumption. (A) The model with
Parameter Set A was simulated with a gradually growing dimensionless alcohol input that
approximates three alcohol consumption peaks per day (as shown in the 24-hour inset)
and an abrupt withdrawal after 500 hours (B) The resultant controller activity, expressed
as number of NMDARs translocated to the synapse per hour. In response to the changing
levels of active, unblocked NMDARs at the synapse, the activity controller (dark red)
moves NMDARs from the extrasynaptic pool to the synapse, while the density controller
(navy blue) removes NMDARs from the synapse. The overall, composite controller
activity is shown in grey. (C) Dynamics of unblocked (red), blocked (blue), and total
(purple) NMDARs at the synapse in response to the alcohol profile shown in Panel A.
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4.2 A Robust, Tunable Composite Controller
The proposed composite controller consists of six primary parameters: ymax1, n1,
a1(A), ymax2, n2, and a2, where a1 is a function of alcohol concentration involving three
secondary parameters: ax, az, and ka (Equations 11-13). The steady state controller
activity varies with changes in the primary parameters as shown in Figure 15. Increases
in alcohol concentration enhance the actions of the activity controller through its effect
on a1 (Equation 13). This provides a mechanism for incorporating alterations in the
apparent set point during long-term exposure to alcohol, which is one hypothesis for the
development of alcohol dependence6, 14, 15, 44.
Clinical reports suggest a wide variety among individuals’ neuroexcitatory
activity during alcohol dependence and withdrawal based on genetics34, gender9, and
behavior42. The proposed composite controller is tunable to approximate a range of
activity. Figure 16 shows the simulated results for four alternative controller
configurations (Parameters Sets B-E, Table 1) responding to the same alcohol input
(Equation 26). The magnitude and duration of the predicted excitotoxicity following
withdrawal varies considerably among these alternative configurations.
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Figure 15. Steady state controller actions for various primary parameter alterations. The
number of NMDARs translocated to the synapse per hour by each controller with various
values of ymax (A), n (B), and a (C). In each panel, the action of the activity controller is
positive, changing in response to ΔU, whereas the action of the density controller is
negative and changes according to ΔT. Parameter values were altered in common
intervals across both controllers. For (A), ymax = 5 (red), 10 (orange), 15 (yellow), 20
(green), 25 (blue), and 30 (purple) receptors/hour. For (B), n = 1 (red), 2 (orange), 3
(yellow), 4 (green), 5 (blue), and 6 (purple). For (C), a = 25 (red), 50 (orange), 75
(yellow), 100 (green), 125 (blue), and 150 (purple) receptors. Parameter values not
explicitly changed are those of Parameter Set A. Increased alcohol concentration
decreases the value of a1, as shown by the open arrow in (C).
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Table 1
Controller Parameter Sets.
Parameter
ymax1 (rec/hr)
n1
ax (rec)
az (rec)
ka
ymax2 (rec/hr)
n2
a2 (rec)
Figure(s)

Set A
25
2
50
50
0.5
25
2
100
14,15*

Set B
25
2
50
50
0.5
12.5
2
100
16A

Set C
25
4
50
50
0.5
25
4
100
16B

Set D
25
2
25
25
0.5
25
2
50
16C

Set E
25
4
25
25
0.5
25
4
50
16D-23

Values of parameters used for various analyses and the figures associated with the
corresponding analyses. Bolded numbers highlight differences from Parameter Set A. *:
For each panel of Figure 15, the indicated parameter was altered from its nominal value
in Parameter Set A.
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Figure 16. The magnitude and duration of predicted excitotoxicity varies with controller
configuration. In response to the alcohol input of Equation 26 (shown in Figure 14A), the
number of blocked (blue) and unblocked (red) NMDARs at the synapse varies with
controller configuration. Controller parameters are listed in Table 1: (A) Parameter Set B,
(B) Parameter Set C, (C) Parameter Set D, (D) Parameter Set E. Excitotoxicity is inferred
when the number of unblocked receptors at the synapse is greater than 100 (the arbitrarily
defined explicit set point).
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4.3 Consumption Patterns Leading to Dependence Do Not Influence Predicted
Withdrawal Severity
Clinicians have no control over the alcohol consumption pattern that leads to
alcohol dependence, and frequently the pattern is unknown. In order to gauge the relative
import of specific consumption patterns on predicted withdrawal severity, four alcohol
consumption patterns were simulated. Parameter Set E was selected for these
investigations, because, as shown in Figure 16, this configuration led to moderately
severe predicted withdrawal upon cessation of alcohol input. As shown in Table 2 and the
insets of Figure 17, all four proposed alcohol inputs involve a gradually increasing
dimensionless alcohol level that ends abruptly after 500 hours. The profiles vary in
consumption pattern from an idealized linear increase to a randomized pattern of intake.

The simulated results of NMDAR levels at the synapse are shown in Figure 17.
Interestingly, the severity of alcohol withdrawal, as quantified by the area under the curve
and the maximum number of unblocked receptors at the synapse, does not change
appreciably (<10%, Table 2). In fact, as long as the consistency of exposure, peak ethanol
concentration, and withdrawal profile are similar, the severity of withdrawal is largely the
same. This suggests that although withdrawal severity differs considerably with
controller parameters (Figure 16, akin to different activities in different individuals), the
specific pattern of alcohol consumption with a given duration prior to withdrawal does
not affect predicted withdrawal severity (Figure 17, Table 2).

It is important to note that this assumes that the controller parameters remain
constant, and do not vary in response to chronic ethanol. It is possible that the values of
these parameters are dependent on disturbances via ethanol, either directly or as a result
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of neuroexcitatory cascades, which would add an additional layer of complexity to this
issue.

Figure 17. The specific pattern of alcohol consumption prior to withdrawal does not
affect withdrawal severity. The number of unblocked (red) and blocked (blue) NMDARs
at the synapse for various dimensionless alcohol consumption patterns (green insets). For
periodic increases (A), constantly increasing levels (B), incremental increases (C), and
randomly distributed dimensionless alcohol levels (D), the excitotoxicity after withdrawal
is relatively uniform for the given parameter set (Parameter Set E, Table 1).
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Table 2
Measures of withdrawal severity for the four alcohol dependence profiles tested.

Alcohol Profile

{

Withdrawal

Area Under

Unblocked

Profile

Curve

Max

Equation 26

{

𝑡 ≥ 500
}
𝐴(𝑡) = 0

2893

107.77

𝐴(𝑡) = 0.0025𝑡

{

𝑡 ≥ 500
}
𝐴(𝑡) = 0

2743

107.77

𝐴(𝑡 = 0) = 0
𝐼𝑛𝑐𝑟𝑒𝑚𝑒𝑛𝑡𝑎𝑙
𝑖𝑛𝑐𝑟𝑒𝑎𝑠𝑒 𝑜𝑓}
{
0.125 𝑒𝑣𝑒𝑟𝑦 50 ℎ𝑜𝑢𝑟𝑠

{

𝑡 ≥ 500
}
𝐴(𝑡) = 0

2743

107.77

{

𝑡 ≥ 500
}
𝐴(𝑡) = 0

2680

107.77

𝑝 ≤ 0.1 𝐴(𝑡) = 𝐴(𝑡 − 1) + 0.1
}
𝑝 > 0.1 𝐴(𝑡) = 𝐴(𝑡𝑙𝑎𝑠𝑡 )𝑒 −0.01(𝑡𝑙𝑎𝑠𝑡 −𝑡
Where p is a randomly generated
probability and tlast is the time alcohol
was last consumed.

The corresponding dynamic responses are shown in Figure 17.

4.4 Alcohol Consumption During Withdrawal Affects Predicted Withdrawal
Severity
During withdrawal, administration of ethanol and other NMDAR antagonists has
been shown to decrease the severity of withdrawal symptoms in humans and rodents and
decrease excitotoxicity in cultured neurons32, 33. Unfortunately, the frequency and dosage
of NMDAR antagonist administration in in-patient settings is driven symptomatically and
administered reactively. This model provides the opportunity to try any withdrawal
pattern risk-free and evaluate the predicted withdrawal severity, even patterns that are not
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easily implemented clinically. This could lead to proactive administration of antagonist
thereby preventing symptoms and excitotoxic damage.

Whereas the alcohol pattern leading to dependence did not influence the
quantified measures of withdrawal appreciably, the alcohol pattern during withdrawal has
a large impact on these measures. For the pre-withdrawal alcohol input given in Equation
26 for t < 500hr, Figure 18 shows the predicted synaptic NMDAR populations during six
withdrawal regimes. These regimes include complete cessation (Figure 18A), exponential
decay (Figure 18B), step-wise decreases (Figure 18C), and linearly decreasing alcohol
profiles with various initial amounts (Figures 18D-F). The quantified severity of
withdrawal is shown in Table 3. As expected, additional alcohol present during the
withdrawal period decreases the severity of withdrawal, primarily in terms of the area
under the curve. The maximum number of unblocked receptors observed is fairly
consistent during all withdrawal regimes tested. This is expected to be a function of the
controller parameters, which were constant for all withdrawal regimes tested here.
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Figure 18. Alcohol levels during withdrawal affect the severity of withdrawal. The
number of unblocked (red) and blocked (blue) NMDARs at the synapse in response to
various withdrawal patterns (green insets). The full time course is shown in (A). The
remaining panels show only t > 400hr, the region inside the dashed box in (A). The
response is identical in all withdrawal schemes at t < 500hr. Withdrawal was initiated at t
= 500hr in various patterns: (A) abrupt and complete cessation; (B) exponential decrease
of alcohol; (C) gradual incremental decreases; (D) constant decrease from ½ maximum
alcohol level; (E) constant decrease from ¾ maximum alcohol level; (F) constant
decrease from maximum alcohol level.
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Table 3
Measures of withdrawal severity for the six withdrawal profiles tested.
Alcohol

Withdrawal Profile

Profile

Area Under

Unblocked

Curve

Max

Equation 15

𝑡 ≥ 500
{
}
𝐴(𝑡) = 0

2883

107.77

Equation 15

𝑡 ≥ 500
{
}
𝐴(𝑡) = 𝐴𝑚𝑎𝑥 𝑒 −0.015(𝑡−𝑡𝑤𝑖𝑡ℎ𝑑𝑟𝑎𝑤 )

54.1

100.64

Equation 15

{

𝑡 ≥ 500
𝐴(𝑡) = 𝐴𝑚𝑎𝑥
}
𝑆𝑡𝑒𝑝 𝐷𝑜𝑤𝑛 0.1 𝑒𝑣𝑒𝑟𝑦 30 ℎ𝑜𝑢𝑟𝑠

2883

107.66

Equation 15

𝑡 ≥ 500
{
}
𝐴(𝑡) = 0.5𝐴𝑚𝑎𝑥 − 0.003(𝑡 − 𝑡𝑤𝑖𝑡ℎ𝑑𝑟𝑎𝑤 )

260.5

101.38

Equation 15

{

𝑡 ≥ 500
}
𝐴(𝑡) = 0.75𝐴𝑚𝑎𝑥 − 0.003(𝑡 − 𝑡𝑤𝑖𝑡ℎ𝑑𝑟𝑎𝑤 )

157.3

101.38

𝑡 ≥ 500
}
𝐴(𝑡) = 𝐴𝑚𝑎𝑥 − 0.003(𝑡 − 𝑡𝑤𝑖𝑡ℎ𝑑𝑟𝑎𝑤 )

19.3

101.11

Equation 15

{

The corresponding dynamic responses are shown in Figure 18.
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The sudden drop in unblocked receptors and peak in blocked receptors observed
in the ramp, step down, and exponential decay profiles may seem counterintuitive; a peak
in unblocked receptors is expected to coincide with observed withdrawal symptoms.
However, this behavior is due to the shift from periodic to sustained alcohol levels. When
the alcohol level deviates between large values and zero (as it does at t < 500hr), the
controller activity mimics these changes. Consistent controller response, however, leads
to a large increase in the number of synaptic receptors, but the high ethanol level
initiating this consistent response means that the receptors are quickly blocked, and
become unblocked gradually as alcohol level diminishes. This suggests that even if it
were possible to maintain a non-zero alcohol level during in-patient withdrawal, the
effects on NMDAR-mediated neuroexcitatory processes would not be favorable.

4.5 Measures of Dependence
One of the goals of this study was to determine whether there is some quantitative
measure of whether or not a patient has developed physical dependence on ethanol. Prior
analysis has shown that the path by which dependence is achieved has little effect on
subsequent measures of withdrawal symptoms. It is, however, still to be determined
whether the consumption profile affects the development of dependence.

In examining this question, there are a number of parameters which much be
considered. Foremost among these is the quantity, frequency, and duration of ethanol
consumption. To study the effects of these parameters on the development of
dependence, two ethanol consumption profiles were proposed. First, a step function is
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considered to determine the combined effects of varying duration and amplitude of
consumption. Second, a periodic function with fixed amplitude is considered to
determine the effects of varying frequency and amplitude. These ethanol profiles are
shown in Figure 19.
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Figure 19. Patterns of ethanol consumption used in the study of dependence
development. The Heaviside step function profile (top) involves a constant alcohol input
for a predetermined amount of time. Both the duration and amplitude can be varied. The
periodic function is the positive portion of a sine wave, where both the frequency and
amplitude can be varied.
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In order to test the effects of these parameters on the development of dependence,
two trials were performed. First, the control system was studied using various
constructions of the step function, where the alcohol input was varied from 0 to 1.00 by
steps of 0.05 and the duration of consumptions was varied from 0 to 1000 hours by steps
of 50 hours. The time allowed for the development of withdrawal symptoms was held
constant at 500 additional hours beyond the time of withdrawal. Second, the control
system was studied with the periodic consumption profile, where the amplitude of
consumption was varied from 0 to 1.00 by steps of 0.05 and the frequency was varied
from 0 to 5.00 by steps of 0.25. Controller parameter Set E was used for these trials
(Table 1).

For each trial, both the maximum number of unblocked receptors and the area
under the NMDA curve were recorded. The series of data were superimposed and plotted
in order to identify possible patterns which could be used to indicate dependence. The
results are shown in Figures 20 and 21.
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Figure 20. Measures of dependence vary with both duration and amplitude of
consumption. The results show that both maximum number of receptors (top) and the
area under the NMDA curve (bottom) vary with similar patterns in response to changes in
the amplitude and duration of alcohol consumption. It is observed that as long as
sufficient alcohol is in the system (amplitude ≥ 0.1) a similar pattern of withdrawal is
observed.
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Figure 21. Measures of dependence vary with frequency and amplitude of consumption.
Both the maximum number of unblocked receptors (top) and the area under the NMDA
curve (bottom) vary with both frequency and amplitude as long as a minimum threshold
of ethanol is met (amplitude ≥ 0.10). The peaks observed are similar to those observed in
the step function study.
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In both studies, a sharp peak is observed as long as a minimum threshold of
ethanol is achieved for a relatively short duration or low frequency. This threshold is an
amplitude of approximately 0.10 for this set of controller parameters and conditions. It is
hypothesized that the slope upwards towards the peak represents the onset and
development of dependence, while all points after the peak tend to have high measures of
both withdrawal extent and severity, representative of a fully dependent system.

The periodic ethanol disturbance function shows a response that decays with
frequency. This is believed to be representative of the limitations of the controller for the
given set of parameters. That is to say that beyond the excitotoxic peak, the frequency of
alcohol consumption is high enough that the controller cannot effectively keep up with
the fluctuations. This may be representative of the kinds of acute consumption that do not
lead to maladaptive alterations in synaptic function and composition.

The similar behaviors observed in these plots is believed to be due to comparable
areas under the alcohol curve, which can be taken as similar total exposure over time.
This result implies that it should be possible to come to a mathematical description of
dependence using area under the alcohol curve as a baseline for exposure, with
modifications to consider the duration and frequency of exposure.

In order to gain a better understanding of exactly how these parameters interact,
the data was plotted in three-dimensions, rather than as a series of superimposed datasets.
The results, shown in Figures 22 and 23, show that a similar peak is observed in all four
cases. However the shape of the curve is slightly different depending on parameter
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limitations, which shows that each parameter affects the development of dependence
differently.

Figure 22. Surface mesh plots of measures of withdrawal versus duration and amplitude.
Mesh surface plots of the duration and amplitude of ethanol consumption against the
maximum number of unblocked receptors (top) and area under the NMDA curve
(bottom) show that measures of withdrawal are largely independent of these parameters
as long as a minimum threshold of exposure is met.
66

Figure 23. Surface mesh plots of measures of withdrawal versus amplitude, and
frequency. Mesh surface plots of the duration and amplitude of ethanol consumption
against the maximum number of unblocked receptors (top) and area under the NMDA
curve (bottom) show that measures of withdrawal are largely independent of these
parameters as long as a minimum threshold of exposure is met. Plots of frequency and
amplitude against maximum number of unblocked receptors (top right) and area under
the NMDA curve (bottom right) show that frequency of consumption has a more
dramatic effect on the shape of the curve describing the development of dependence.
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The results obtained in this study are consistent with previous results in that the
development of physical dependence does not vary substantially with duration or
amplitude. As long as enough ethanol is present for a minimum threshold of time,
dependence will be developed and withdrawal symptoms will be observed. It can,
however, be observed that variations in frequency can dramatically changes the curvature
of the cross-sections describing the development of dependence. This suggests that any
mathematical measure of dependence will be largely based on a combination of total
ethanol exposure, measured by area under the ethanol curve, and the frequency at which
the individual is exposed. It is important to note that the time scales used in this study are
arbitrary, and are used to show trends in behaviors which could be fitted to future clinical
and experimental data.

4.6 Investigation of the Potential for Patient-Specific Modeling
One of the goals of this study is to demonstrate the possibility of developing plans
of care that take into account patient-specific degrees of dependence and unique
neurochemical dynamics. In this case, differences in neurochemical behavior are
accounted for exclusively through changes in controller parameters. Of particular interest
is the balance between the parameters ymax1 and ymax2 as well as a1 and a2. This is because
ymax1 and ymax2 represent the maximum controller action attainable by the activity and
density controllers respectively, and changes in the balance between these controllers will
significantly affect controller behavior when both subcontrollers are active. Similarly, a1
and a2 represent the threshold at which the subcontrollers become active, and could
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determine the extent to which dependence can develop and the likelihood of emergent
withdrawal symptoms.

In order to study the effects that variations in these controller parameters have on
measures of withdrawal, a trial was performed where ymax1 and ymax2 were varied from 10
to 150 in steps of 7 using Parameter Set E (Table 1) and the periodic ethanol profile with
abrupt withdrawal shown in Figures 17A and 18A. Similarly, a second trial was
performed where a1 and a2 were varied from 50 to 150 in steps of 5. For the purposes of
better understanding the controller dynamics, the effect of alcohol on a1 was ignored, and
the final value of a1 was varied directly. The results of these trials are in Figures 24 and
25.
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Figure 24. Surface mesh plots of measures of withdrawal versus ymax1 and ymax2. When
ymax1 and ymax2 are small, there is no observed deviation in the number of unblocked
receptors (top) due to the system’s inability to respond to the ethanol disturbance. As
ymax1 increases, it is expected that synaptic trafficking will increase. For fixed ymax1,
increasing ymax2 results in an initial increase, followed by a plateau as controller actions
are balanced, and finally a decay as the density controller becomes dominant. Area under
the NMDA curve (bottom) is minimized at high controller actions for both ymax1 and
ymax2, with the dependence on ymax2 appearing to be almost linearly decreasing and
dependence on ymax1 having a sharp change in regime around ymax1 = 100.
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Figure 25. Surface mesh plots of measures of withdrawal versus controller parameters a1
and a2. It is observed that both maximum unblocked receptors (top) and area under the
NMDA curve (bottom) are both effectively independent of a1. This is reasonable because
the system is given time to reach a stable state of ethanol dependence such that there was
time for the controller to overcome deviations in a1. Both measures show regions of
linear dependence with respect to a2, implying that trafficking away from the synapse is
the process which determines the development of withdrawal symptoms.
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In these figures it can be seen that the balance between ymax1 and ymax2 has a much
more dramatic effect on the observed emergence of withdrawal symptom than does a1 or
a2. This is reasonable because of the time scale over which this system is being observed.
Given enough time, the system is able to overcome limitations on controller activity
imposed by a1. It is likely that in trials where the system is not allowed to equilibrate in a
dependence state, that the impact of deviations in a1 would be more substantial.

The observed behaviors with respect to a2 are consistent with expected behaviors.
As the threshold at which the controller begins taking action is increased, the system is
allowed to spend more time in a hyperexcited state before the controller begins taking
corrective actions, resulting in an increased quantity of unblocked receptors and area
under the NMDA curve.

The balance between ymax1 and ymax2 however, has a significant effect on the
system at points where both controllers are active. In particular, this means that the
balance between the maximum actions of these controllers determines the degree to
which dependence is developed and the severity of controller action as ethanol
concentrations are decreasing. It is observed that there are a number of different regimes
of behavior in both maximum number of unblocked receptors and area under the NMDA
curve. Being able to predict these changes in behavior by mapping a patient’s
neurological dynamics to model parameters could be useful in developing a withdrawal
treatment which minimizes the likelihood of severe withdrawal symptoms based on the
degree of dependence, consumption patterns, and predicted regime of controller behavior.
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4.7 Limitations and Caveats
No experimental data measuring the translocation of NMDARs in human brain
tissue was found over the duration of this study. Therefore, the kinetics shown here are
only hypothetical realizations of the control system hypothesis. Wherever possible,
dimensionless (e.g. alcohol level) or easily scalable (e.g. ymax) functions and parameters
were used so that the model could be adapted easily to fit experimental data.

Furthermore, the predicted control actions do not reveal mechanistic information.
For example, it has been established that NMDAR subunit composition changes in
response to alcohol13, 30, 32, 54, promoting a removal NMDARs from the synapse. In the
model, this is represented in the bulk sensing of blocked NMDARs and removal of
receptors by the density subcontroller.

Finally, it is recognized that the severity of alcohol withdrawal cannot be
predicted by the levels of unblocked NMDARs alone. For example, the neuroinhibitory
system (especially GABAA receptors) has been implicated in the brain’s response to
alcohol6, 20, 63. A complete representation of withdrawal would require incorporation of
these additional systems. However, given the excitotoxic nature of the most detrimental
symptoms of alcohol withdrawal (delirium tremens, seizures, etc.), this study has focused
on describing the neuroexcitatory effects of alcohol via NMDARs.
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Chapter 5
Conclusions and Recommendations3
.

In this work, a computational model was developed that is based on a negative
feedback control system hypothesis of NMDAR regulation at the synapse in the presence
of alcohol. The focus of this study is on the hypothesis of the lateral translocation of
NMDARs between the synapse and extrasynaptic regions. The model accomplishes this
via a dual-action control system whereby NMDARs are translocated from an
extrasynaptic pool to the synapse by an activity subcontroller in order to maintain a set
number of unblocked, active NMDARs at the synapse while, simultaneously, NMDARs
are removed from the synapse by a density subcontroller to maintain a constant density of
total NMDARs at the synapse. The composite action of the two subcontrollers aims to
maintain glutamatergic signaling even when NMDARs are blocked by ethanol molecules.

The results show that the proposed composite controller produces simulated
dynamics consistent with qualitative experimental data describing the biophysical causes
of both dependence and withdrawal across a range of values for controller parameters.
This means that the model is highly tunable, containing seven parameters which can
change the maximum controller response (ymax), the threshold of activity (a), the
curvature (n), and sensitivity to ethanol (amax). Consequently, it could be fit to any
experimental data published in the future, and could subsequently provide powerful
insights into individualized dependence and withdrawal dynamics.

3

Substantial portions of this chapter were adapted from Gutierrez and Staehle57
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Ethanol functions as a disturbance to this system, engaging homeostatic controller
action to maintain a desired neruoexcitatory state. A variety of disturbance functions
were imposed during both dependence and withdrawal (Figures 12 and 13) to determine
how the emergence of withdrawal symptoms changed in response. Results suggest that
withdrawal severity is not influenced by the manner in which alcohol dependence is
achieved, provided that the state of dependence is similar. That is to say, as long as the
levels of ethanol exposure are sufficiently high for any extended period of time,
dependence will develop. This suggests that for a particular individual (analogously, a
particular set of controller parameters), the prediction of withdrawal severity depends on
the characterization of the current state of dependence (frequency, quantity, and duration
of alcohol consumption) and the specific parameters of the individual’s NMDAR
controller activity. It is important to note that this study assumes that the controller
parameters (a, ymax, n) remain constant throughout a simulation. It is possible, even likely,
that these parameters are dependent on patient-specific factors such as age, gender, and
general health, or even parallel neuroexcitatory signaling cascades. Furthermore,
prolonged ethanol exposure could modulate parameter values. These effects and the
resultant behaviors warrant future investigation.

The severity of alcohol withdrawal is substantially influenced by the alcohol input
during withdrawal. This is consistent with experimental results that showed that
administration of NMDAR antagonists such as ethanol reduce the negative effects of
alcohol withdrawal8, while the administration of NMDAR agonists such as NMDA
increase the severity of withdrawal symptoms7,27. The results of this work show that the
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most effective means of reducing excitotoxicity involve exacerbating the response with
increased total alcohol. This is then followed by carefully decreasing alcohol levels over
a prolonged period of time. This is not likely to be a viable option clinically, but the
model provides tremendous flexibility for conducting in silico investigations of
alternative withdrawal profiles, which provides the opportunity to gain a better
understanding of how changes in the dependence and withdrawal profiles can affect the
outcomes of excitotoxic withdrawal and long-term changes to system dynamics and to
generate testable hypotheses.
However, all of this data was determined for a system which was “sufficiently
ethanol-dependent,” meaning that the system had equilibrated at a state of inhibition due
to prolonged ethanol exposure. That means that there is interest in determining if there is
a means by which the extent of dependence can be measured, as this weighs heavily in
the determination of appropriate treatment. To that end, the system was studied using a
Heaviside step function and sine wave to study the effects of amplitude, duration, and
frequency of ethanol consumption on the development of dependence.

The results obtained in the study of the development of dependence are consistent
with previous results that all paths to dependence lead to a similar equilibrated
dependence state. There are three regimes which can be identified. First, there are regions
where too little alcohol is consumed to substantially change the development of
withdrawal symptoms. Second, there are planar regions at which an equilibrated state of
dependence has been achieved. Third, there are regions between, the curvature of which
is highly dependent on the frequency of consumption moreso than the magnitude or
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duration of ethanol exposure. This kind of multivariate determination of a dependency
surface is unlikely to have direct clinical applications, but means that there is room for
additional work in developing a simpler and more comprehensive measure of
dependence.

Finally, the model was studied to determine the effect that model parameters have
on the development of withdrawal symptoms when the ethanol disturbance is held
constant. This is intended to simulate the substantial variations in a population’s
susceptibility to becoming dependent and subsequently developing withdrawal
symptoms. These differences in expected outcomes are a consequence of differences in
age, gender, general health, and unique neuroexcitatory dynamics. For baseline analysis,
it is hypothesized that these differences can be considered as a change in the balance
between the minimum threshold of action and the gains of the activity and density
controllers. To that end, two pairs of controller parameters, ymax1 and ymax2 as well as a1
and a2, were varied and the severity of withdrawal symptoms were determined.

It was observed that a2 and the balance of ymax1 and ymax2 were found to have a
substantial impact on the severity of withdrawal for a given state of dependence. This
means that from the same state of equilibrated dependence, the withdrawal profile that
minimizes the development of symptoms will not necessarily be the same for two unique
sets of controller parameters (patients).

To summarize, the results of this study are a robust, tuneable, dual-action control
system model for the relocation of NMDARs in response to neuroexcitatory ethanol
disturbances. Baseline results are consistent with anticipated behaviors. The model
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provides the ability to predict proposed measures of withdrawal severity, and shows, for a
given set of controller parameters, that these measures depend primarily on the path taken
to reduce ethanol exposure from a state of equilibrated dependence. Further analysis of
the paths taken to achieve dependence show that a dependence surface can be generated
for a given set of controller parameters to show various degrees of the development of
equilibrated dependence and that the shape of this surface changes dramatically with the
frequency of consumption. Finally, it is shown that changes in the balance of controller
parameters have dramatic effects on withdrawal outcomes, meaning that the model
parameters can be varied to more closely match an individual patient.

The goal of this study was to build upon previous work towards developing a
more comprehensive model of the neuroexcitatory control of NMDARs in response to
ethanol disturbances for the purposes of better understanding withdrawal dynamics and
the potential for proposing proactive, personalized treatment paths for patients. To that
end, there is still substantial work left to be done.

First, there are a multitude of additional layers of neuroexcitatory complexity
which can be considered and implemented. Various parallel mechanisms for modulation
of NMDAR population composition and activity were outlined, including modulation by
nitric oxides and phosphorylation. This study assumes that the controller parameters (a,
ymax, n) are constants. As additional clinical and experimental data becomes available, it
is possible that the effects of these parallel neuroexcitatory processes could be captured
by introducing some functionality of these controller parmaeters with respect to
phosphorylation, nitric oxides, and presence of other ions and neuroexcitatory agents.
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The model has not been tested to see if behaviors of physical dependence can be
accurately modeled. To test this, a second, independent control system could be
developed which tries to control the neuroexcitatory state by varying the alcohol
disturbance function once a state of dependence has been achieved. This controller would
measure the number of unblocked NMDARs at the synapse, and would “drink” whenever
the excitatory state exceeded a given number of unblocked receptors to maintain an
ethanol-dependent homeostasis. Critical variables include the threshold for controller
activity, and the shape and magnitude of the subsequent ethanol disturbance. These
results could allow for the prediction of the behaviors of individuals who have developed
physical dependence on ethanol.

Current analysis of the development of dependence is based on two individual
sets of two parameters: the duration and amplitude of a Heaviside step function and the
amplitude and frequency of a sine wave. Based on the shapes of the surfaces obtained
from these analyses, it seems likely that duration and amplitude could be grouped
together and measured by the area under the alcohol curve. This could allow for a more
robust, two-component model whereby dependence is measured by a frequency of
consumption and area under the ethanol curve. This hypothesis can be tested by
generating dependence surfaces for an extensive array of disturbance profiles to
determine if the surfaces are sufficiently similar.

This dependence analysis would also allow for further study of withdrawal
dynamics. If a reasonable measure of the extent of dependence can be developed, this
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allows for the analysis of withdrawal dynamics beginning at different points on the
dependence surface.
This study only considered two pairs of parameters: ymax1 and ymax2 as well as a1
and a2. The parameters n1 and n2 were not considered in this study; the reasons for this
are two-fold. The first is that the effect that these changes have on the control system are
easy to understand as a shift in either the maximum control action or threshold at which
the control begins taking homeostatic actions, while changes in n1 and n2 result in
changed curvature. The second reason is that analysis of n1 and n2 resulted in issues with
discontinuity which have not yet been satisfactorily resolved.

Finally, the end goal of future work in this vein is to develop a mechanism by
which the withdrawal profile that minimizes the emergence of excitotoxic behaviors for a
given dependence state and set of controller parameters can be identified. If this model
can be fitted to data for clinical or experimental withdrawal dynamics, this would allow
for the prediction of treatment plans which would minimize withdrawal outcomes.

There are several means by which this might be accomplished. A simple solution
would be to test changes in ethanol content and use the model to identify which change
minimizes the deviation variable in the next time step. If each time step is optimized in
this way, the results should roughly approximate a path which minimizes withdrawal
parameters. Alternatively, a database of withdrawal profiles and curvatures could be
developed as part of the process for testing dependence surfaces, and unique problems
could be matched to prior cases which most closely match the current problem. Finally,
the most rigorous solution likely involves the generation of individualized dependence
and withdrawal surfaces, with the use of gradients to determine the path by which
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dependence can be most quickly reduced with minimal emergence of excitotoxic
symptoms.
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Appendix A
Raw Code for Varying Withdrawal and Dependence Profiles in Visual Basic
Applications

This is the code for the base case of the bimodal controller hypothesis for
NMDAR-mediated ethanol withdrawal as described in Figures 17A and 18A.
A.1 Sinusoid with Abrupt Withdrawal – Base Case
'Initial Conditions + Variables to track
Public Alcohol(0 To 200000) As Single 'Array for tracking
Alcohol Content with Time
Public C1Action(0 To 200000) As Single 'Array for tracking
Controller 1 Action with Time.
Public C2Action(0 To 200000) As Single 'Array for tracking
Controller 2 Action with Time.
Public CTAction(-5 To 200000) As Single 'Array for tracking
Total Controller Action with Time.
Public UnblockedS(0 To 200000) As Single 'Array for
tracking Unblocked receptors at the synapse.
Public BlockedS(0 To 200000) As Single 'Array for tracking
Blocked receptors at the synapse.
Public UnblockedP(0 To 200000) As Single 'Array for
tracking Unblocked receptors in the extrasynaptic pool.
Public TotalS(0 To 200000) As Single 'Array for tracking
Total receptors at the synapse.
Public T As Single
'Loop Counter
'Parameters for elementary kinetics.
Public k1 As Single
Public k2 As Single
Public UsDesired As Single 'Desired number of receptors at
the synapse.
Public Deviation1 As Single 'Deviation from set point for
Activity Controller (1)
Public Deviation2 As Single 'Deviation from set point for
Density Controller (2)
Dim AreaUnderCurve As Single 'Used to track area under
alcohol curve after withdrawal is imposed.
Dim UsMax As Single
'Used to track the maximum
number of unblocked receptors at the synapse after
withdrawal is imposed.
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'Controller One Parameters (Activity). Controls relocation
TO synapse.
Public n1 As Single
Public anorm As Single
Public amax As Single
Public ka As Single
Public ymax1 As Single
'Controller two parameters (Density). Controls relocation
FROM synapse.
Public ymax2 As Single
Public a2 As Single
Public n2 As Single
Public Coverage As Single 'Geometric/Physical limitation on
the number of receptors which can be fit at the synapse.
Public Excess As Single 'The number of receptors in excess
of the coverage constraint which the controller attempted
to insert.
Sub RelocationOnly()
'Define and Read Alcohol Parameters
Dim P As Single
'Periodicity
Dim G As Single
Dim tend As Single
'total length of simulation
Public Amplitude As Single 'Amplitude of Sinusoid
Dim withdrawtime As Single 'time at which withdrawal
occurs
P = Sheet1.Cells(9, 2).Value
G = Sheet1.Cells(10, 2).Value
tend = Sheet1.Cells(11, 2).Value
withdrawtime = Sheet1.Cells(13, 2).Value
Amplitude = Sheet1.Cells(14, 2).Value
'Define and Read Kinetics, Controller Parameters,and
Initial Conditions
k1 = Sheet1.Cells(2, 2).Value
k2 = Sheet1.Cells(3, 2).Value
n1 = Sheet1.Cells(22, 2).Value
anorm = Sheet1.Cells(23, 2).Value
amax = Sheet1.Cells(24, 2).Value
ymax1 = Sheet1.Cells(25, 2).Value
ka = Sheet1.Cells(26, 2).Value
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ymax2 = Sheet1.Cells(28, 2).Value
a2 = Sheet1.Cells(29, 2).Value
n2 = Sheet1.Cells(30, 2).Value
Coverage = Sheet1.Cells(32, 2).Value
UsDesired = Sheet1.Cells(27, 2).Value
UnblockedS(0) = Sheet1.Cells(35, 2).Value
BlockedS(0) = Sheet1.Cells(37, 2).Value
UnblockedP(0) = Sheet1.Cells(36, 2).Value
TotalS(0) = UnblockedS(0) + BlockedS(0)
UsMax = UnblockedS(0)
AreaUnderCurve = 0
‘Iterate for the full time interval
For T = 0 To tend Step 0.1
'Calculate Current Alcohol
Alcohol(T) = Amplitude * Sin(P * T) * Exp(G * T)
If T > withdrawtime Then 'Imposes abrupt withdrawal at
withdrawtime.
Alcohol(T) = 0
ElseIf Alcohol(T) < 0 Then 'Forces alcohol to be >=
zero.
Alcohol(T) = 0
End If
'Calculate Current Controller Action
C1Action(T) = Controller1Action(UnblockedS(T), Alcohol(T))
'Calls a function which calculates Controller 1 Action.
C2Action(T) = Controller2Action(TotalS(T)) 'Calls a
function which calculates Controller 2 Action
CTAction(T) = C1Action(T) - C2Action(T)
'Calculate new values for NMDARs at various positions for
next step
UnblockedS(T + 1) = UnblockedS(T) + (-k1 * Alcohol(T) *
UnblockedS(T)) + k2 * BlockedS(T) + CTAction(T)
UnblockedP(T + 1) = UnblockedP(T) - CTAction(T)
BlockedS(T + 1) = BlockedS(T) + k1 * UnblockedS(T) *
Alcohol(T) - k2 * BlockedS(T)
UnblockedP(T + 1) = UnblockedP(T) - CTAction(T)
TotalS(T + 1) = BlockedS(T + 1) + UnblockedS(T + 1)
'Check for new Unblocked Max
If UnblockedS(T + 1) > UsMax Then
UsMax = UnblockedS(T + 1)
End If
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'Check for coverage, send excess back to pool
If TotalS(T + 1) > 175 Then
Excess = TotalS(T + 1) - 175
UnblockedS(T + 1) = UnblockedS(T + 1) - Excess
TotalS(T + 1) = 175
UnblockedP(T + 1) = UnblockedP(T + 1) + Excess
End If
'Area Under the Curve Approximation
If T > withdrawtime Then
If UnblockedS(T - 1) > UsDesired Then
If UnblockedS(T) > UsDesired Then 'Check if both this
time step and previous were above set point.
IntegralCheck = 0.05 * (UnblockedS(T - 1) +
UnblockedS(T) - 2 * UsDesired) 'Midpoint approximation of
area between those time steps
AreaUnderCurve = AreaUnderCurve + IntegralCheck
End If
End If
End If
'Record in Spreadsheet
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet6.Cells(10 * T + 2,
Sheet6.Cells(10 * T + 2,
Sheet6.Cells(10 * T + 2,

1).Value
2).Value
3).Value
4).Value
5).Value
6).Value
7).Value
8).Value
1).Value
2).Value
3).Value

=
=
=
=
=
=
=
=
=
=
=

T
Alcohol(T)
BlockedS(T)
UnblockedS(T)
UnblockedP(T)
C1Action(T)
C2Action(T)
CTAction(T)
T
Deviation1
Deviation2

Next T
'Report Area Under Curve and UsMax
Sheet1.Cells(13, 6).Value = AreaUnderCurve
Sheet1.Cells(14, 6).Value = UsMax
End Sub
‘Definition of Functions which calculate controller actions
Function Controller1Action(Unblocked As Single, Alcohol As
Single) As Single
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Dim a1 As Single
Deviation1 = UsDesired - Unblocked
If Deviation1 > 0 Then 'Controller Actions are defined
positive until net controller action is calculated.
a1 = anorm + amax * Exp(-ka * Alcohol)
Controller1Action = ymax1 * (1 - (a1 ^ n1 / (Deviation1 ^
n1 + a1 ^ n1))) 'Calculate Controller 1 Action
Else
Controller1Action = 0
End If
End Function
Function Controller2Action(Total As Single) As Single
Deviation2 = Total - UsDesired
If Deviation2 > 0 Then
Controller2Action = ymax2 * (Deviation2 ^ n2 / (a2 ^ n2 +
Deviation2 ^ n2))
Else
Controller2Action = 0
End If
End Function
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A.2 Code for Dependence Profiles
These lines are inserted in place of the Sinusoid in the previous code under ‘Calculate
Current Alcohol,” and are the profiles generated in Figure 12.

Linear Alcohol Profile
'Calculate Current Alcohol
Alcohol(T) = M * T + B
If T > withdrawtime Then
Alcohol(T) = 0
ElseIf Alcohol(T) < 0 Then
Alcohol(T) = 0
End If

Step-Up Alcohol Profile
'Calculate Current Alcohol
If T < 1 Then
Alcohol(T) = 0
ElseIf StepCount = StepFrequency * 10 Then
frequency.

'Count step

Alcohol(T) = Alcohol(T - 0.1) + StepSize 'Add StepSize
to previous alcohol at step frequency.
StepCount = 0
'Reset Step Count.
Else
Alcohol(T) = Alcohol(T - 0.1)
'Otherwise, alcohol
says constant, step count increments.
StepCount = StepCount + 1
End If
If T > withdrawtime Then
Alcohol(T) = 0
End If

Random Consumption with Exponential Decay
'Calculate Current Alcohol
Randomize
Flag = Int(100 * Rnd) + 1 'generate a random integer
If Flag <= Probability Then 'Check probability
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Alcohol(T) = Alcohol(T - 1) + PlusAlcohol 'Subject
"drinks" a fixed amount of alcohol.
LastAlcoholMax = Alcohol(T) 'Store local alcohol
maximum.
TimeLast = T 'Store time of local alcohol maximum
'If there is no "drink," ethanol exposure begins to decay
exponentially.
Else
Alcohol(T) = LastAlcoholMax * Exp(-Decay * (T TimeLast))
End If
If T > withdrawtime Then
Alcohol(T) = 0
End If
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A.3 Code for Withdrawal Profiles
These lines are inserted in after the statement “if t < withdrawtime,” and represent the
imposed withdrawal profiles generated in Figure 13.
Abrupt Withdrawal Profile
If T > withdrawtime Then
Alcohol(T) = 0
End If

Step-Down Withdrawal Profile
If T > withdrawtime Then
If StepCount = StepFrequency Then
Alcohol(T) = Alcohol(T - 1) - StepDown 'Take a
fixed step down every StepCount
StepCount = 0
Else
Alcohol(T) = Alcohol(T - 1) 'Otherwise Alcohol
is constant and StepCount is incremented.
StepCount = StepCount + 1
End If
End If

Linear Withdrawal Profile
If T > withdrawtime Then
Alcohol(T) = AlcoholMax - SlopeDown * (T withdrawtime)
End If

Exponential Decay Withdrawal Profile
If T > withdrawtime Then
Alcohol(T) = AlcoholMax * Exp(-Decay * (T withdrawtime))
End If
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Appendix B
Raw Code for Varying Amplitude and Duration of Dependence of Step Function

'Iterate for Various Time intervals and Alcohol Amplitudes
For K = 0 To 20
amax = 0.05 * K 'Varies amplitude for each trial
For J = 0 To 20
withdrawtime = 50 * J
each trial.

'Varies Withdrawal time for

'Reset Checks
Usmax = 0
BlockedSMax = 0
TotalSMax = 0
AreaUnderCurve = 0
AlcoholAreaUnderCurve = 0
For T = 0 To withdrawtime + 500 Step 0.1
'Calculate Alcohol For Step
If T < withdrawtime Then
Alcohol(T) = amax
Else
Alcohol(T) = 0
End If
'Calculate Current Controller Action
C1Action(T) = Controller1Action(UnblockedS(T), Alcohol(T))
C2Action(T) = Controller2Action(TotalS(T))
CTAction(T) = C1Action(T) - C2Action(T)
'Calculate new values for NMDARs at various positions for
next step
UnblockedS(T + 1) = UnblockedS(T) + (-k1 * Alcohol(T) *
UnblockedS(T)) + k2 * BlockedS(T) + CTAction(T) + kd *
(CTAction(T - 1) - CTAction(T - 2)) + ki * (CTAction(T - 1)
+ CTAction(T - 2) + CTAction(T - 3))
UnblockedP(T + 1) = UnblockedP(T) - CTAction(T)
BlockedS(T + 1) = BlockedS(T) + k1 * UnblockedS(T) *
Alcohol(T) - k2 * BlockedS(T)
UnblockedP(T + 1) = UnblockedP(T) - CTAction(T)
TotalS(T + 1) = BlockedS(T + 1) + UnblockedS(T + 1)
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'Check USMax
If UnblockedS(T + 1) > Usmax Then
Usmax = UnblockedS(T + 1)
End If
If BlockedS(T + 1) > BlockedSMax Then
BlockedSMax = BlockedS(T + 1)
End If
If TotalS(T + 1) > TotalSMax Then
TotalSMax = TotalS(T + 1)
End If
‘Record Alcohol Profile for Middle Case
If J = 10 Then
If K = 10 Then
'Record in Spreadsheet
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet6.Cells(10 * T + 2,
Sheet6.Cells(10 * T + 2,
Sheet6.Cells(10 * T + 2,
End If
End If

1).Value
2).Value
3).Value
4).Value
5).Value
6).Value
7).Value
8).Value
1).Value
2).Value
3).Value

=
=
=
=
=
=
=
=
=
=
=

T
Alcohol(T)
BlockedS(T)
UnblockedS(T)
UnblockedP(T)
C1Action(T)
C2Action(T)
CTAction(T)
T
Deviation1
Deviation2

'Area Under the Curve Approximation for Trial
If T > withdrawtime Then
If UnblockedS(T - 1) > UsDesired Then
If UnblockedS(T) > UsDesired Then 'Check if both this
time step and previous were above set point.
IntegralCheck = 0.05 * (UnblockedS(T - 1) +
UnblockedS(T) - 2 * UsDesired) 'Midpoint approximation of
area between those time steps
AreaUnderCurve = AreaUnderCurve + IntegralCheck
End If
End If
End If
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Next T
'Store Data for Trial
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +
AlcoholAreaUnderCurve
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +

J + 2, 1).Value = withdrawtime
J + 2, 2).Value = amax
J + 2, 3).Value =
J
J
J
J

+
+
+
+

2,
2,
2,
2,

4).Value
5).Value
6).Value
7).Value

Next J
Next K
End Sub
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=
=
=
=

Usmax
BlockedSMax
TotalSMax
AreaUnderCurve

Appendix C
Raw Code for Varying Amplitude and Frequency of Sinusoidal Dependence

'Iterate for Various Time intervals and Alcohol Amounts
For K = 0 To 20
amax = 0.05 * K ‘Vary Amplitude for each trial
For J = 0 To 20
P = J * 0.0125 ‘Vary Frequency for each trial
'Reset Checks
Usmax = 0
BlockedSMax = 0
TotalSMax = 0
AreaUnderCurve = 0
AlcoholAreaUnderCurve = 0
For T = 0 To 1000 Step 0.1
'Calculate Alcohol For Step
Alcohol(T) = amax * Sin(P * T)
If Alcohol(T) < 0 Then
Alcohol(T) = 0
End If
If T > 500 Then
Alcohol(T) = 0
End If
'Calculate Current Controller Action
C1Action(T) = Controller1Action(UnblockedS(T), Alcohol(T))
C2Action(T) = Controller2Action(TotalS(T))
CTAction(T) = C1Action(T) - C2Action(T)
'Calculate new values for NMDARs at various positions for
next step
UnblockedS(T + 1) = UnblockedS(T) + (-k1 * Alcohol(T) *
UnblockedS(T)) + k2 * BlockedS(T) + CTAction(T) + kd *
(CTAction(T - 1) - CTAction(T - 2)) + ki * (CTAction(T - 1)
+ CTAction(T - 2) + CTAction(T - 3))
UnblockedP(T + 1) = UnblockedP(T) - CTAction(T)
BlockedS(T + 1) = BlockedS(T) + k1 * UnblockedS(T) *
Alcohol(T) - k2 * BlockedS(T)
UnblockedP(T + 1) = UnblockedP(T) - CTAction(T)
TotalS(T + 1) = BlockedS(T + 1) + UnblockedS(T + 1)
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'Check USMax
If UnblockedS(T + 1) > Usmax Then
Usmax = UnblockedS(T + 1)
End If
If BlockedS(T + 1) > BlockedSMax Then
BlockedSMax = BlockedS(T + 1)
End If
If TotalS(T + 1) > TotalSMax Then
TotalSMax = TotalS(T + 1)
End If
‘Record Alcohol Profile for Middle Case
If J = 10 Then
If K = 10 Then
'Record in Spreadsheet
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet6.Cells(10 * T + 2,
Sheet6.Cells(10 * T + 2,
Sheet6.Cells(10 * T + 2,
End If
End If

1).Value
2).Value
3).Value
4).Value
5).Value
6).Value
7).Value
8).Value
1).Value
2).Value
3).Value

=
=
=
=
=
=
=
=
=
=
=

T
Alcohol(T)
BlockedS(T)
UnblockedS(T)
UnblockedP(T)
C1Action(T)
C2Action(T)
CTAction(T)
T
Deviation1
Deviation2

'Area Under the Curve Approximation for Trial
If T > withdrawtime Then
If UnblockedS(T - 1) > UsDesired Then
If UnblockedS(T) > UsDesired Then 'Check if both this
time step and previous were above set point.
IntegralCheck = 0.05 * (UnblockedS(T - 1) +
UnblockedS(T) - 2 * UsDesired) 'Midpoint approximation of
area between those time steps
AreaUnderCurve = AreaUnderCurve + IntegralCheck
End If
End If
End If
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Next T
'Store Data for Trial
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +
AlcoholAreaUnderCurve
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +

J + 2, 1).Value = withdrawtime
J + 2, 2).Value = amax
J + 2, 3).Value =
J
J
J
J

+
+
+
+

2,
2,
2,
2,

4).Value
5).Value
6).Value
7).Value

Next J
Next K
End Sub
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=
=
=
=

Usmax
BlockedSMax
TotalSMax
AreaUnderCurve

Appendix D
Raw Code for Varying Controller Parameters ymax1 and ymax2

'Iterate for Combinations of ymax1 and ymax2
For K = 0 To 20
ymax1 = 10 + 7 * K
For J = 0 To 20
ymax2 = 10 + 7 * J
'Reset Checks
Usmax = 0
BlockedSMax = 0
TotalSMax = 0
AreaUnderCurve = 0
AlcoholAreaUnderCurve = 0
For T = 0 To 1000 Step 0.1
'Calculate Alcohol For Step
Alcohol(T) = Sin(0.75 * T) * Exp(0.0005 * T)
If T >= 500 Then
Alcohol(T) = 0
ElseIf Alcohol(T) < 0 Then
Alcohol(T) = 0
End If
'Calculate Current Controller Action
C1Action(T) = Controller1Action(UnblockedS(T), Alcohol(T))
C2Action(T) = Controller2Action(TotalS(T))
CTAction(T) = C1Action(T) - C2Action(T)
'Calculate new values for NMDARs at various positions for
next step
UnblockedS(T + 1) = UnblockedS(T) + (-k1 * Alcohol(T) *
UnblockedS(T)) + k2 * BlockedS(T) + CTAction(T) + kd *
(CTAction(T - 1) - CTAction(T - 2)) + ki * (CTAction(T - 1)
+ CTAction(T - 2) + CTAction(T - 3))
UnblockedP(T + 1) = UnblockedP(T) - CTAction(T)
BlockedS(T + 1) = BlockedS(T) + k1 * UnblockedS(T) *
Alcohol(T) - k2 * BlockedS(T)
UnblockedP(T + 1) = UnblockedP(T) - CTAction(T)
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TotalS(T + 1) = BlockedS(T + 1) + UnblockedS(T + 1)
'Check USMax
If UnblockedS(T + 1) > Usmax Then
Usmax = UnblockedS(T + 1)
End If
If BlockedS(T + 1) > BlockedSMax Then
BlockedSMax = BlockedS(T + 1)
End If
If TotalS(T + 1) > TotalSMax Then
TotalSMax = TotalS(T + 1)
End If
‘Record Alcohol Profile for Middle Case
If J = 10 Then
If K = 10 Then
'Record in Spreadsheet
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet6.Cells(10 * T + 2,
Sheet6.Cells(10 * T + 2,
Sheet6.Cells(10 * T + 2,
End If
End If

1).Value
2).Value
3).Value
4).Value
5).Value
6).Value
7).Value
8).Value
1).Value
2).Value
3).Value

=
=
=
=
=
=
=
=
=
=
=

T
Alcohol(T)
BlockedS(T)
UnblockedS(T)
UnblockedP(T)
C1Action(T)
C2Action(T)
CTAction(T)
T
Deviation1
Deviation2

'Area Under the Curve Approximation for Trial
If T > withdrawtime Then
If UnblockedS(T - 1) > UsDesired Then
If UnblockedS(T) > UsDesired Then 'Check if both this
time step and previous were above set point.
IntegralCheck = 0.05 * (UnblockedS(T - 1) +
UnblockedS(T) - 2 * UsDesired) 'Midpoint approximation of
area between those time steps
AreaUnderCurve = AreaUnderCurve + IntegralCheck
End If
End If
End If
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Next T
'Store Data for Trial
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +
AlcoholAreaUnderCurve
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +

J + 2, 1).Value = withdrawtime
J + 2, 2).Value = amax
J + 2, 3).Value =
J
J
J
J

+
+
+
+

2,
2,
2,
2,

4).Value
5).Value
6).Value
7).Value

Next J
Next K
End Sub
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=
=
=
=

Usmax
BlockedSMax
TotalSMax
AreaUnderCurve

Appendix E
Raw Code for Varying Controller Parameters a1 and a2

'Iterate for Various Combinations of a1 and a2
For K = 0 To 20
a1 = 50 + 5 * K
For J = 0 To 20
a2 = 50 + 5 * J
'Reset Checks
Usmax = 0
BlockedSMax = 0
TotalSMax = 0
AreaUnderCurve = 0
AlcoholAreaUnderCurve = 0
For T = 0 To 1000 Step 0.1
'Calculate Alcohol For Step
Alcohol(T) = Sin(0.75 * T) * Exp(0.0005 * T)
If T >= 500 Then
Alcohol(T) = 0
ElseIf Alcohol(T) < 0 Then
Alcohol(T) = 0
End If
'Calculate Current Controller Action
C1Action(T) = Controller1Action(UnblockedS(T), Alcohol(T))
C2Action(T) = Controller2Action(TotalS(T))
CTAction(T) = C1Action(T) - C2Action(T)
'Calculate new values for NMDARs at various positions for
next step
UnblockedS(T + 1) = UnblockedS(T) + (-k1 * Alcohol(T) *
UnblockedS(T)) + k2 * BlockedS(T) + CTAction(T) + kd *
(CTAction(T - 1) - CTAction(T - 2)) + ki * (CTAction(T - 1)
+ CTAction(T - 2) + CTAction(T - 3))
UnblockedP(T + 1) = UnblockedP(T) - CTAction(T)
BlockedS(T + 1) = BlockedS(T) + k1 * UnblockedS(T) *
Alcohol(T) - k2 * BlockedS(T)
UnblockedP(T + 1) = UnblockedP(T) - CTAction(T)
TotalS(T + 1) = BlockedS(T + 1) + UnblockedS(T + 1)
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'Check USMax
If UnblockedS(T + 1) > Usmax Then
Usmax = UnblockedS(T + 1)
End If
If BlockedS(T + 1) > BlockedSMax Then
BlockedSMax = BlockedS(T + 1)
End If
If TotalS(T + 1) > TotalSMax Then
TotalSMax = TotalS(T + 1)
End If
‘Record Alcohol Profile for Middle Case
If J = 10 Then
If K = 10 Then
'Record in Spreadsheet
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet2.Cells(10 * T + 2,
Sheet6.Cells(10 * T + 2,
Sheet6.Cells(10 * T + 2,
Sheet6.Cells(10 * T + 2,
End If
End If

1).Value
2).Value
3).Value
4).Value
5).Value
6).Value
7).Value
8).Value
1).Value
2).Value
3).Value

=
=
=
=
=
=
=
=
=
=
=

T
Alcohol(T)
BlockedS(T)
UnblockedS(T)
UnblockedP(T)
C1Action(T)
C2Action(T)
CTAction(T)
T
Deviation1
Deviation2

'Area Under the Curve Approximation for Trial
If T > withdrawtime Then
If UnblockedS(T - 1) > UsDesired Then
If UnblockedS(T) > UsDesired Then 'Check if both this
time step and previous were above set point.
IntegralCheck = 0.05 * (UnblockedS(T - 1) +
UnblockedS(T) - 2 * UsDesired) 'Midpoint approximation of
area between those time steps
AreaUnderCurve = AreaUnderCurve + IntegralCheck
End If
End If
End If
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Next T
'Store Data for Trial
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +
AlcoholAreaUnderCurve
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +
Sheet8.Cells(21 * K +

J + 2, 1).Value = withdrawtime
J + 2, 2).Value = amax
J + 2, 3).Value =
J
J
J
J

+
+
+
+

2,
2,
2,
2,

4).Value
5).Value
6).Value
7).Value

Next J
Next K
End Sub
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=
=
=
=

Usmax
BlockedSMax
TotalSMax
AreaUnderCurve

